Publications of Pharmacy Practice - Research Nebraska

Publications

This is a list of publications by researchers in this unit, listed chronologically starting with the most recent first. New publications appear in this list weekly. Previous years may be selected using the dropdown menu. The source of publications for this application is Scopus.

Publications from Scopus

Select All | Save icon

Export

1.
2013

Lina Lander; Donald G. Klepser; Gary L. Cochran; Daniel E. Lomelin; Marsha Morien

Barriers to electronic prescribing: Nebraska pharmacists' perspective
Journal of Rural Health 2013;29(1):119-124.
2.
2011

Diane E Beck; Jeffrey N Baldwin; Cynthia L Raehl; Marilyn K Speedie; Victor A Yanchick; Robert Buzz A Kerr

Roles of the Pharmacy Academy in informing consumers about the new American pharmacist: 2010-2011 Argus Commission Report.
American journal of pharmaceutical education 2011;75(10):S5.
3.
2013

Gautam Baheti; Timothy R. McGuire; Jasmine P. Davda; Konstantine K. Manouilov; Donna Wall; Peter R. Gwilt; Bruce B. Gordon

Clinical pharmacology of etoposide in children undergoing autologous stem cell transplantation for various solid tumours
Xenobiotica 2013;43(3):276-282.
4.
2013

Theodore J. Cory; Timothy W. Schacker; Mario Stevenson; Courtney V. Fletcher

Overcoming pharmacologic sanctuaries
5.
2013

Julie H. Oestreich; Suellen P. Ferraris; Steven R. Steinhubl; Wendell S. Akers

Pharmacodynamic interplay of the P2Y1, P2Y12, and TxA2 pathways in platelets: The potential of triple antiplatelet therapy with P2Y1 receptor antagonism
Thrombosis Research 2013;131(2):e64-e70.
6.
2013

Dale W. Bratzler; E. Patchen Dellinger; Keith M. Olsen; Trish M. Perl; Paul G. Auwaerter; Maureen K. Bolon; Douglas N. Fish; Lena M. Napolitano; Robert G. Sawyer; Douglas Slain; et al.

Clinical practice guidelines for antimicrobial prophylaxis in surgery
American Journal of Health-System Pharmacy 2013;70(3):195-283.
7.
2013

Gautam Baheti; Jennifer R. King; Edward P. Acosta; Courtney V. Fletcher

Age-related differences in plasma and intracellular tenofovir concentrations in HIV-1-infected children, adolescents and adults
AIDS 2013;27(2):221-225.
8.
2013

Shadi F. Othman; Thomas Boulet; Huihui Xu; Matthew L. Kelso

Brain mechanical imaging (BMI)
Conference Proceedings of the Society for Experimental Mechanics Series 2013;5():87-92.
9.
2013

S. Alex Marshall; Justin A. McClain; Matthew L. Kelso; Deann M. Hopkins; James R. Pauly; Kimberly Nixon

Microglial activation is not equivalent to neuroinflammation in alcohol-induced neurodegeneration: The importance of microglia phenotype
10.
2013

Dale W. Bratzler; E. Patchen Dellinger; Keith M. Olsen; Trish M. Perl; Paul G. Auwaerter; Maureen K. Bolon; Douglas N. Fish; Lena M. Napolitano; Robert G. Sawyer; Douglas Slain; et al.

Clinical practice guidelines for antimicrobial prophylaxis in surgery
Surgical Infections 2013;14(1):73-156.
11.
2012

Paul P. Dobesh; Craig J. Beavers; Holly R. Herring; Sarah A. Spinler; Zachary A. Stacy; Toby C. Trujillo

Key articles and guidelines in the management of acute coronary syndrome and in percutaneous coronary intervention: 2012 Update
Pharmacotherapy 2012;32(12):e348-e386.
12.
2012

Corrine Hanson; Melissa Thoene; Julie Wagner; Dean Collier; Kassandra Lecci; Ann Anderson-Berry

Parenteral nutrition additive shortages: The short-term, long-term and potential epigenetic implications in premature and hospitalized infants
Nutrients 2012;4(12):1977-1988.
13.
2012

Uriel Sandkovsky; Susan Swindells; Brian L. Robbins; Sarah R. Nelson; Edward P. Acosta; Courtney V. Fletcher

Measurement of plasma and intracellular concentrations of raltegravir in patients with HIV infection
AIDS 2012;26(17):2257-2259.
14.
2012

Brian L. Robbins; Sarah R. Nelson; Courtney V. Fletcher

A novel ultrasensitive LC-MS/MS assay for quantification of intracellular raltegravir in human cell extracts
Journal of Pharmaceutical and Biomedical Analysis 2012;70():378-387.
15.
2012

Victor A. Ferraris; Sibu P. Saha; Julie H. Oestreich; Howard K. Song; Todd Rosengart; T. Brett Reece; C. David Mazer; Charles R. Bridges; George J. Despotis; Kanae Jointer; et al.

2012 update to the society of thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations
Annals of Thoracic Surgery 2012;94(5):1761-1781.
16.
2012

Marilyn K Speedie; Jeffrey N Baldwin; Rodney A Carter; Cynthia L Raehl; Victor A Yanchick; Lucinda L Maine

Cultivating 'habits of mind' in the scholarly pharmacy clinician: report of the 2011-12 Argus Commission.
American journal of pharmaceutical education 2012;76(6):S3.
17.
2012

Jennifer J. Kiser; Rui Zhu; David Z. D'Argenio; Mark F. Cotton; Raziya Bobat; George D. McSherry; Shabir A. Madhi; Vincent J. Carey; Heiner I. Seifart; Cedric J. Werely; et al.

Isoniazid pharmacokinetics, pharmacodynamics, and dosing in South African infants
Therapeutic Drug Monitoring 2012;34(4):446-451.
18.
2012

Janelle B. Perkins; Jamie F. Shapiro; Ryan N. Bookout; Gary C. Yee; Claudio Anasetti; William E. Janssen; Hugo F. Fernandez

Retrospective comparison of filgrastim plus plerixafor to other regimens for remobilization after primary mobilization failure: Clinical and economic outcomes
American Journal of Hematology 2012;87(7):673-677.
19.
2012

Matthew L. Kelso; Julie H. Oestreich

Traumatic brain injury: Central and peripheral role of α7 nicotinic acetylcholine receptors
Current Drug Targets 2012;13(5):631-636.
20.
2012

Jayashri Sankaranarayanan; Dean Collier; Anne Furasek; Tom Reardon; Lynette M. Smith; Megan McCartan; Alan N. Langnas

Rurality and other factors associated with adherence to immunosuppressant medications in community-dwelling solid-organ transplant recipients
Research in Social and Administrative Pharmacy 2012;8(3):228-239.
21.
2012

Craig M. Coopersmith; Hannah Wunsch; Mitchell P. Fink; Walter T. Linde-Zwirble; Keith M. Olsen; Marilyn S. Sommers; Kanwaljeet J. S. Anand; Kathryn M. Tchorz; Derek C. Angus; Clifford S. Deutschman

A comparison of critical care research funding and the financial burden of critical illness in the United States
Critical Care Medicine 2012;40(4):1072-1079.
22.
2012

Rui Zhu; Jennifer J. Kiser; Heiner I. Seifart; Cedric J. Werely; Charles D. Mitchell; David Z. D'Argenio; Courtney V. Fletcher

The pharmacogenetics of NAT2 enzyme maturation in perinatally HIV exposed infants receiving isoniazid
Journal of Clinical Pharmacology 2012;52(4):511-519.
23.
2010

A. Amin; A.C. Spyropoulos; P. Dobesh; A. Shorr; M. Hussein; E. Mozaffari; J.S. Benner

Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start)
Journal of Thrombosis and Thrombolysis 2010;29(3):326-339.
24.
2010

J.H. Oestreich

Elinogrel, a reversible P2Y12 receptor antagonist for the treatment of acute coronary syndrome and prevention of secondary thrombotic events
Current Opinion in Investigational Drugs 2010;11(3):340-348.
25.
2010

Elizabeth D Hermsen; Monica Hanson; Jayashri Sankaranarayanan; Julie A Stoner; Marius C Florescu; Mark E Rupp

Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections
Expert Opinion on Drug Safety 2010;9(1):9-14.
26.
2010

Wendell S. Akers; Jennifer J. Oh; Julie H. Oestreich; Suellen Ferraris; Mary Wethington; Steven R. Steinhubl

Pharmacokinetics and pharmacodynamics of a bolus and infusion of cangrelor: A direct, parenteral P2Y12 receptor antagonist
Journal of Clinical Pharmacology 2010;50(1):27-35.
27.
2010

C. Daniel Mullins; Brian Seal; Enrique Seoane-Vazquez; Jayashri Sankaranarayanan; Carl V. Asche; Ravishankar Jayadevappa; Won Chan Lee; Dorothy K. Romanus; Junling Wang; Joel W. Hay; et al.

Good research practices for measuring drug costs in cost-effectiveness analyses: Medicare, medicaid and other US Government payers perspectives: The ISPOR drug cost task force report - Part IV
Value in Health 2010;13(1):18-24.
28.
2010

S.A. Morris; M.L. Kelso; D.J. Liput; S.A. Marshall; K. Nixon

Similar withdrawal severity in adolescents and adults in a rat model of alcohol dependence
Alcohol 2010;44(1):89-98.
29.
2010

Kimberly Nixon; Stephanie A. Morris; Daniel J. Liput; Matthew L. Kelso

Roles of neural stem cells and adult neurogenesis in adolescent alcohol use disorders
Alcohol 2010;44(1):39-56.
30.
2010

Tien M.H. Ng; Keith M. Olsen; Megan A. McCartan; Susan E. Puumala; Katie M. Speidel; Melissa A. Miller; Tom D. Sears

Drug-induced QTc-interval prolongation in the intensive care unit: Incidence and predictors
Journal of Pharmacy Practice 2010;23(1):19-24.
31.
2008

Gina G. Wardyn; Stephen I. Rennard; Susan K. Brusnahan; Timothy R. McGuire; Mary L. Carlson; Lynette M. Smith; Sandra McGranaghan; John G. Sharp

Effects of exercise on hematological parameters, circulating side population cells, and cytokines
Experimental Hematology 2008;36(2):216-223.
32.
2008

Alison Freifeld; Jayashri Sankaranarayanan; Fred Ullrich; Junfeng Sun

Clinical practice patterns of managing low-risk adult febrile neutropenia during cancer chemotherapy in the USA
Supportive Care in Cancer 2008;16(2):181-191.
33.
2008

J.J. Kiser; M.L. Carten; C.L. Aquilante; P.L. Anderson; P. Wolfe; T.M. King; T. Delahunty; L.R. Bushman; C.V. Fletcher

The effect of lopinavir/ritonavir on the renal clearance of tenofovir in HIV-infected patients
Clinical Pharmacology and Therapeutics 2008;83(2):265-272.
34.
2008

Ali Khoynezhad; Paul P. Dobesh; Zachary Stacy; Ziba Jalali

The role of intravenous dihydropyridine calcium channel blockers in the perioperative management of patients undergoing coronary artery bypass surgery
Current Vascular Pharmacology 2008;6(3):186-194.
35.
2008

Jennifer J. Kiser; Courtney V. Fletcher; Patricia M. Flynn; Coleen K. Cunningham; Craig M. Wilson; Bill G. Kapogiannis; Hanna Major-Wilson; Rolando M. Viani; Nancy X. Liu; Larry R. Muenz; et al.

Pharmacokinetics of antiretroviral regimens containing tenofovir disoproxil fumarate and atazanavir-ritonavir in adolescents and young adults with human immunodeficiency virus infection
Antimicrobial Agents and Chemotherapy 2008;52(2):631-637.
36.
2008

Wonkyung Byon; Courtney V. Fletcher; Richard C. Brundage

Impact of censoring data below an arbitrary quantification limit on structural model misspecification
Journal of Pharmacokinetics and Pharmacodynamics 2008;35(1):101-116.
37.
2008

Ellen G. Chadwick; Edmund V. Capparelli; Ram Yogev; Jorge A. Pinto; Brian Robbins; John H. Rodman; Jie Chen; Paul Palumbo; Leslie Serchuck; Elizabeth Smith; et al.

Pharmacokinetics, safety and efficacy of lopinavir/ritonavir in infants less than 6 months of age: 24 Week results
AIDS 2008;22(2):249-255.
38.
2008

Steven R. Steinhubl; Jennifer J. Oh; Julie H. Oestreich; Suellen Ferraris; Richard Charnigo; Wendell S. Akers

Transitioning patients from cangrelor to clopidogrel: Pharmacodynamic evidence of a competitive effect
Thrombosis Research 2008;121(4):527-534.
39.
2008

Jeffrey N. Baldwin

A guided abstinence experience to illustrate addiction recovery principles
40.
2007

Akihiko Saitoh; Terence Fenton; Carmelita Alvero; Courtney V. Fletcher; Stephen A. Spector

Impact of nucleoside reverse transcriptase inhibitors on mitochondria in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy
Antimicrobial Agents and Chemotherapy 2007;51(12):4236-4242.
41.
2007

Donald G. Klepser; Jeffrey R. Huether; Lee J. Handke; Clint E. Williams

Effect on drug utilization and expenditures of a cost-share change from copayment to coinsurance
Journal of Managed Care Pharmacy 2007;13(9):765-777.
42.
2005

Yi-Min Ku; Megan McCartan; Dean Collier

Clinical pharmacokinetic and pharmacodynamic monitoring for mycophenolate mofetil
Journal of Pharmacy Practice 2005;18(6):422-431.
43.
2005

John W. Devlin; Lynda S. Welage; Keith M. Olsen

Proton pump inhibitor formulary considerations in the acutely ill. Part 2: Clinical efficacy, safety, and economics
Annals of Pharmacotherapy 2005;39(11):1844-1851.
44.
2005

Courtney V. Fletcher; Marcia A. Testa; Richard C. Brundage; Margaret A. Chesney; Richard Haubrich; Edward P. Acosta; Ana Martinez; Hongyu Jiang; Roy M. Gulick

Four measures of antiretroviral medication adherence and virologic response in AIDS clinical trials group study 359
Journal of Acquired Immune Deficiency Syndromes 2005;40(3):301-306.
45.
2005

Paul P Dobesh; Zachary A Stacy

Effect of a clinical pharmacy education program on improvement in the quantity and quality of venous thromboembolism prophylaxis for medically ill patients.
Journal of managed care pharmacy : JMCP. 2005;11(9):755-762.
46.
2005

John W. Devlin; Lynda S. Welage; Keith M. Olsen

Proton pump inhibitor formulary considerations in the acutely Ill: Part 1 - Pharmacology, pharmacodynamics, and available formulations
Annals of Pharmacotherapy 2005;39(10):1667-1677.
47.
2005

Paul P. Dobesh

Enoxaparin appears as effective as unfractionated heparin for people with high risk non-ST elevation acute coronary syndromes receiving rapid invasive therapy: Commentary
Evidence-based Cardiovascular Medicine 2005;9(3):180-183.
48.
2005

T.R. McGuire; W.J. Trickler; L. Smith; E.B. Hoie; D.W. Miller

Release of TNF-α and IL-1β from porcine brain endothelium corresponds to the pyrogenic potential of three marketed formulations of amphotericin
Inflammation Research 2005;54(9):375-379.
49.
2005

Gary L. Davis; David R. Nelson; Norah Terrault; Timothy L. Pruett; Thomas D. Schiano; Courtney V. Fletcher; Christine V. Sapan; Laura N. Riser; Yufeng Li; Richard J. Whitley; et al.

A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients
Liver Transplantation 2005;11(8):941-949.
50.
2005

Thomas B. Campbell; Nancy S. Shulman; Steven C. Johnson; Andrew R. Zolopa; Russell K. Young; Lane Bushman; Courtney V. Fletcher; E. Randall Lanier; Thomas C. Merigan; Daniel R. Kuritzkes

Antiviral activity of lamivudine in salvage therapy for multidrug-resistant HIV-1 infection
Clinical Infectious Diseases 2005;41(2):236-242.
51.
2003

Timothy R. McGuire; William J. Trickler; Lynette Hock; Amy Vrana; Eric B. Hoie; Donald W. Miller

Release of prostaglandin E-2 in bovine brain endothelial cells after exposure to three unique forms of the antifungal drug amphotericin-B: Role of COX-2 in amphotericin-B induced fever
Life Sciences 2003;72(23):2581-2590.
52.
2003

Thu T. Tran; Brian L. Robbins; Frank H. Pinkerton Jr.; Bernard Ferrua; Jacques Grassi; Arnold Fridland

A new sensitive cartridge-RIA method for determination of stavudine (D4T) triphosphate in human cells in vivo
Antiviral Research 2003;58(2):125-129.
53.
2003

Michael E. Klepser; Donald G. Klepser; Erika J. Ernst; John Brooks; Daniel J. Diekema; Essy Mozaffari; Joseph Hendrickson; Gary V. Doern

Health care resource utilization associated with treatment of penicillin-susceptible and -nonsusceptible isolates of Streptococcus pneumoniae
Pharmacotherapy 2003;23(3):349-359.
54.
2003

Timothy R. McGuire; Peter Gwilt; Konstantine Manouvilov; Kathleen Healey; M.M. Ursick; Richard A. Nash; Steven Z. Pavletic

High-dose cyclophosphamide in multiple sclerosis patients undergoing autologous stem cell transplantation
International Immunopharmacology 2003;3(2):279-283.
55.
2003

Martin H. Ellbogen; Keith M. Olsen; Martha J. Gentry-Nielsen; Laurel C. Preheim

Efficacy of liposome-encapsulated ciprofloxacin compared with ciprofloxacin and ceftriaxone in rat model of pneumococcal pneumonia
Journal of Antimicrobial Chemotherapy 2003;51(1):83-91.
56.
2002

Jason M. Enders; John M. Burke; Paul P. Dobesh

Prevention of venous thromboembolism in acute medical illness
Pharmacotherapy 2002;22(12 I):1564-1578.
57.
2002

Bradley A. Bucher; Keith M. Olsen

Drotrecogin alfa (activated) in the management of sepsis: Introduction
Pharmacotherapy 2002;22(12 II):167S-168S.
58.
2002

Keith M. Olsen; Steven J. Martin

Pharmacokinetics and clinical use of drotrecogin alfa (activated) in patients with severe sepsis
Pharmacotherapy 2002;22(12 II):196S-205S.
59.
2002

Keith M. Olsen; Kyle Skiermont; G. Douglas Campbell Jr.

Antibiotic pharmacodynamics for clinicians: A summary of the basics
Journal of Respiratory Diseases 2002;23(11):561-568.
60.
2002

Alex C. McLaren; Sandra G. McLaren; Carl L. Nelson; David L. Wassell; Keith M. Olsen

The effect of sampling method on the elution of tobramycin from calcium sulfate
61.
2002

Laura A. Guay; Philippa Musoke; David L. Hom; Clemensia Nakabiito; Danstan Bagenda; Courtney V. Fletcher; Lawrence H. Marum; Mary Glenn Fowler; Lars G. Falksveden; et al.

Erratum: Phase I/II trial of HIV-1 hyperimmune globulin for the prevention of HIV-1 vertical transmission in Uganda (Aids (2002) 16 (1391-1400))
AIDS 2002;16(14):1989-.
62.
2002

Roy M. Gulick; X. Joan Hu; Susan A. Fiscus; Courtney V. Fletcher; Richard Haubrich; Hailong Cheng; Edward Acosta; Stephen W. Lagakos; Ronald Swanstrom; William Freimuth; et al.

Durability of response to treatment among antiretroviral-experienced subjects: 48-Week results from AIDS Clinical Trials Group Protocol 359
Journal of Infectious Diseases 2002;186(5):626-633.
63.
2002

Paul P. Dobesh; Jonathan E. Lakamp

Educational program to reduce major bleeding in patients undergoing percutaneous coronary interventions and receiving abciximab
American Journal of Health-System Pharmacy 2002;59(16):1539-1542.
64.
2002

James R. Berenson; Bruce E. Hillner; Robert A. Kyle; Ken Anderson; Allan Lipton; Gary C. Yee; J. Sybil Biermann

American society of clinical oncology clinical practice guidelines: The role of bisphosphonates in multiple myeloma
Journal of Clinical Oncology 2002;20(17):3719-3736.
65.
2002

Sara L. Schroeder; Paul P. Dobesh; Joy R. Abu-Shanab; Jonathan E. Lakamp

Knowledge of hospital acquisition costs of antibiotics among physicians in a community hospital
Hospital Pharmacy 2002;37(8):833-839.
66.
2002

Paul P. Dobesh; Jennifer B. Kasiar

Administration of glycoprotein IIb-IIIa inhibitors in patients with ST-segment elevation myocardial infarction
Pharmacotherapy 2002;22(7):864-888.
67.
2000

E.P. Acosta; T.N. Kakuda; R.C. Brundage; P.L. Anderson; C.V. Fletcher

Pharmacodynamics of human immunodeficiency virus type 1 protease inhibitors
Clinical Infectious Diseases 2000;30(SUPPL. 2):S151-S159.
68.
2000

Jill A. Rebuck; Keith M. Olsen; Paul D. Fey; Alan N. Langnas; Mark E. Rupp

Characterization of an outbreak due to extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a pediatric intensive care unit transplant population
Clinical Infectious Diseases 2000;31(6):1368-1372.
69.
2000

S.A. Spector; K. Hsia; F.H. Yong; S. Cabral; T. Fenton; C.V. Fletcher; J. McNamara; L.M. Mofenson; S.E. Starr

Patterns of plasma human immunodeficiency virus type 1 RNA response to highly active antiretroviral therapy in infected children
Journal of Infectious Diseases 2000;182(6):1769-1773.
70.
2000

W.T. Shearer; R.J. Israel; S. Starr; C.V. Fletcher; D. Wara; M. Rathore; J. Church; J. DeVille; T. Fenton; B. Graham; et al.

Recombinant CD4-IgG2 in human immunodeficiency virus type 1-infected children: Phase 1/2 study
Journal of Infectious Diseases 2000;182(6):1774-1779.
71.
2000

Courtney V. Fletcher; Edward P. Acosta; Hailong Cheng; Richard Haubrich; Margaret Fischl; Ralph Raasch; Charlotte Mills; X. Joan Hu; David Katzenstein; Rory P. Remmel; et al.

Competing drug-drug interactions among multidrug antiretroviral regimens used in the treatment of HIV-infected subjects: ACTG 884
AIDS 2000;14(16):2495-2501.
72.
1999

Stuart E. Starr; Courtney V. Fletcher; Stephen A. Spector; Florence H. Yong; Terence Fenton; Richard C. Brundage; Douglas Manion; Nancy M. Ruiz; Merril Gersten; Mark Becker; et al.

Combination therapy with efavirenz, nelfinavir, and nucleoside reverse- transcriptase inhibitors in children infected with human immunodeficiency virus type 1
New England Journal of Medicine 1999;341(25):1874-1881.
73.
1999

Kimberly L. Bergman; Keith M. Olsen; Tom E. Peddicord; Fey Paul D; Mark E. Rupp

Antimicrobial activities and postantibiotic effects of clarithromycin, 14-hydroxy-clarithromycin, and azithromycin in epithelial cell lining fluid against clinical isolates of Haemophilus influenzae and Streptococcus pneumoniae
Antimicrobial Agents and Chemotherapy 1999;43(5):1291-1293.
74.
1999

Laurel C. Preheim; Keith M. Olsen; Mei Yue; Mary U. Snitily; Martha J. Gentry

Ethanol feeding does not affect the efficacy or pharmacokinetics of azithromycin, trovafloxacin, or ceftriaxone in a rat model of pneumococcal pneumonia
Alcoholism: Clinical and Experimental Research 1999;23(5):842-849.
75.
1999

M.W. Kline; S. Blanchard; C.V. Fletcher; J.L. Shenep; R.E. McKinney Jr.; R.C. Brundage; M. Culnane; R.B. Van Dyke; W.M. Dankner; et al.

A phase I study of abacavir (1592U89) alone and in combination with other antiretroviral agents in infants and children with human immunodeficiency virus infection. AIDS Clinical Trials Group 330 Team.
Pediatrics 1999;103(4):e47.
76.
1999

C.V. Fletcher; T.N. Kakuda; L.M. Page; E.P. Acosta; R.C. Brundage; P.L. Anderson; K. Henry; T. Schacker

Pharmacokinetic strategies for concentration-targeted therapy with zidovudine (ZDV), lamivudine (3TC), and indinavir (IDV)
Clinical Pharmacology and Therapeutics 1999;65(2):161-.
77.
1999

T.N. Kakuda; R.C. Brundage; P.L. Anderson; C.V. Fletcher

Nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity as an etiology for lipodystrophy
AIDS 1999;13(16):2311-2312.
78.
1999

John H. Rodman; Patricia M. Flynn; Brian Robbins; Eleanor Jimenez; Arlene D. Bardeguez; Jose F. Rodriguez; Suzette Blanchard; Arnold Fridland

Systemic pharmacokinetics and cellular pharmacology of zidovudine in human immunodeficiency virus type 1-infected women and newborn infants
Journal of Infectious Diseases 1999;180(6):1844-1850.
79.
1995

B.L. Robbins; J. Greenhaw; M.C. Connelly; A. Fridland

Metabolic pathways for activation of the antiviral agent 9-(2- phosphonylmethoxyethyl)adenine in human lymphoid cells
Antimicrobial Agents and Chemotherapy 1995;39(10):2304-2308.
80.
1995

G.J. Yuen; G.L. Drusano; C. Fletcher; E. Capparelli; J.D. Connor; J.P. Lalezari; L. Drew; S. Follansbee; D. Busch; et al.

Population differences in ganciclovir clearance as determined by nonlinear mixed-effects modelling
Antimicrobial Agents and Chemotherapy 1995;39(10):2350-2352.
81.
1995

C.V. Fletcher

Sexually transmitted viral diseases in the elderly
Journal of Geriatric Drug Therapy 1995;10(2):53-79.
82.
1995

P.W. Kazakoff; T.R. McGuire; E.B. Hoie; M. Gano; P.L. Iversen

An in vitro model for endothelial permeability: Assessment of monolayer integrity
In Vitro Cellular and Developmental Biology - Animal 1995;31(11):846-852.
83.
1994

E.P. Acosta; C.V. Fletcher

Agents for treating human immunodeficiency virus infection
American Journal of Hospital Pharmacy 1994;51(18):2251-2267+2286-2287.
84.
1994

B.L. Robbins; J. Rodman; C. McDonald; R.V. Srinivas; P.M. Flynn; A. Fridland

Enzymatic assay for measurement of zidovudine triphosphate in peripheral blood mononuclear cells
Antimicrobial Agents and Chemotherapy 1994;38(1):115-121.
85.
1994

K.M. Olsen; M.A. Marx; M.S. Monaghan; E. Barnes; B.H. Ackerman; A.A. Pappas

Phenytoin and plasmapheresis: Importance of sampling times and impact of obesity
Therapeutic Drug Monitoring 1994;16(6):624-628.
86.
1994

F.C. Hiller; K.M. Olsen; L.P. Gann; M.L. Erbland

Nicotine blood levels measured after smoking cigarettes designed to release nicotine by heat evaporation (instead of burning)
S.T.P. Pharma Sciences 1994;4(1):77-81.
87.
1994

D.E. Koehntop; S.E. Noormohamed; C.V. Fletcher

Effects of long-term drugs on alfentanil clearance in patients undergoing renal transplantation
Pharmacotherapy 1994;14(5):592-599.
88.
1994

M.S. Monaghan; G. Glasco; G. St. John; R.W. Bradsher; K.M. Olsen

Safe administration of iron dextran to a patient who reacted to the test dose
Southern Medical Journal 1994;87(10):1010-1012.
89.
1994

K.A. Kriegler; J.N. Baldwin; D.M. Scott

A survey of alcohol and other drug use behaviors and risk factors in health profession students
Journal of American College Health 1994;42(6):259-265.
90.
1994

R.V. Srinivas; B.L. Robbins; M.C. Connelly; Y.-F. Gong; N. Bischofberger; A. Fridland

Pivaloyloxymethyl esters of acyclic nucleoside phosphonates
International Antiviral News 1994;2(4):53-55.
91.
1994

C.V. Fletcher; A.C. Collier; F.S. Rhame; D. Bennett; M.F. Para; C.C. Beatty; C.E. Jones; H.H. Balfour Jr.

Foscarnet for suppression of human immunodeficiency virus replication
Antimicrobial Agents and Chemotherapy 1994;38(3):604-607.
92.
1994

M.S. Shaeffer; D. Collier; M.F. Sorrell

Interaction between FK506 and erythromycin [2]
Annals of Pharmacotherapy 1994;28(2):280-281.
93.
1994

G.C. Yee

Bone marrow transplantation - Part 2
American Pharmacy 1994;34(12):64-72.
94.
1994

C.V. Fletcher; E.P. Acosta; J.M. Strykowski

Gender differences in human pharmacokinetics and pharmacodynamics
Journal of Adolescent Health 1994;15(8):619-629.
95.
1994

G.C. Yee

Understanding bone marrow transplantation - Part 1
American Pharmacy 1994;34(11):56-67.
96.
1993

M.C. Connelly; B.L. Robbins; A. Fridland

Mechanism of uptake of the phosphonate analog (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) in vero cells
Biochemical Pharmacology 1993;46(6):1053-1057.
97.
1993

M.S. Monaghan; L. Falls; K.M. Olsen

Potential drug interactions with H2-receptor antagonists in intensive care unit patients
Hospital Pharmacy 1993;28(4):296-297+300.
98.
1987

G.C. Yee; T.P. Lennon; D.J. Gmur; M.S. Kennedy; H.J. Deeg

Effect of age on cyclosporine pharmacokinetics in marrow transplant recipients
Transplantation Proceedings 1987;19(1 II):1704-1705.
99.
1987

B. Bean; C. Fletcher; J. Englund; S. Nusinoff Lehrman; M. Nixon Ellis

Progressive mucocutaneous herpes simplex infection due to acyclovir-resistant virus in an immunocompromised patient: Correlation of viral susceptibilities and plasma levels with response to therapy
Diagnostic Microbiology and Infectious Disease 1987;7(3):199-204.
100.
1987

Janet A. Englund; Courtney V. Fletcher; Dana Johnson; Barbara Chinnock; Henry H. Balfour Jr.

Effect of blood exchange on acyclovir clearance in an infant with neonatal herpes
The Journal of Pediatrics 1987;110(1):151-153.
101.
1986

G.C. Yee; M.S. Kennedy; S.G. Self

Pharmacodynamics of cyclosporine in patients undergoing bone marrow transplantation
Transplantation Proceedings 1986;18(4):774-776.
102.
1987

K. Henry; H. Cantrill; C. Fletcher; B.J. Chinnock; H.H. Balfour Jr.

Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS
American Journal of Ophthalmology 1987;103(1):17-23.
103.
1987

K.M. Olsen; T.C. Coniglione; C.I. Barton

Response of platelets to intravenous iron dextran in reactive thrombocytosis
Clinical Pharmacy 1987;6(5):417-420.
104.
1987

K.M. Olsen; F.C. Hiller

Management of tetanus
Clinical Pharmacy 1987;6(7):570-574.
105.
1987

G.C. Yee; M.S. Kennedy; D.J. Gmur; S.G. Self; H.J. Deeg

Monitoring cyclosporin concentrations in marrow transplant recipients: Comparison of two assay methods
Bone Marrow Transplantation 1987;1(3):289-295.
106.
1987

T.P. Lennon; G.C. Yee; M.S. Kennedy; B. Torok-Storb; S.A. Burstein; H.J. Deeg

Monitoring of cyclosporine therapy with in vitro biological assays
Transplantation 1987;44(6):799-804.
107.
1986

P.W. Abramowitz; C.V. Fletcher

Counterpoint: let's expand the formulary system and renew its vigor.
American Journal of Hospital Pharmacy 1986;43(11):2834-2838.
108.
1986

Gary C. Yee; Thomas P. Lennon; Dennis J. Gmur; Michael S. Kennedy; H.Joachim Deeg

Age-dependent cyclosporine: Pharmacokinetics in marrow transplant recipients
Clinical Pharmacology and Therapeutics 1986;40(4):438-443.
109.
1986

Courtney Fletcher; Ronald Sawchuk; Barbara Chinnock; Paulo de Miranda; Henry H. Balfour Jr.

Human pharmacokinetics of the antiviral drug DHPG
Clinical Pharmacology and Therapeutics 1986;40(3):281-286.
110.
1986

C.V. Fletcher; R.M. Giese; J.H. Rodman

Pharmacist interventions to improve prescribing of vancomycin and tobramycin
American Journal of Hospital Pharmacy 1986;43(9):2198-2201.
111.
2012

Donald G. Klepser; Sara E. Bisanz; Michael E. Klepser

Cost-effectiveness of pharmacist-provided treatment of adult pharyngitis
American Journal of Managed Care 2012;18(4):e145-e154.
112.
2012

Michele C. Balas; Eduard E. Vasilevskis; William J. Burke; Leanne Boehm; Brenda T. Pun; Keith M. Olsen; Gregory J. Peitz; Wesley Ely

Critical care nurses' role in implementing the "ABCDE Bundle" into practice
Critical Care Nurse 2012;32(2):35-47.
113.
2012

Jay P. Bae; Paul P. Dobesh; Donald G. Klepser; Johnna D. Anderson; Anthony J. Zagar; Patrick L. McCollam; Molly E. Tomlin

Adherence and dosing frequency of common medications for cardiovascular patients
American Journal of Managed Care 2012;18(3):139-146.
114.
2008

J.J. Kiser; C.V. Fletcher

Response to "Lack of evidence for an effect of lopinavir/ritonavir on tenofovir renal clearance"
Clinical Pharmacology and Therapeutics 2008;84(6):661-.
115.
2012

Dennis E. McChargue; Jayashri Sankaranarayanan; Constance G. Visovsky; Ellyn E. Matthews; Krista B. Highland; Ann M. Berger

Predictors of adherence to a behavioral therapy sleep intervention during breast cancer chemotherapy
Supportive Care in Cancer 2012;20(2):245-252.
116.
2012

M. Nikanjam; E.G. Chadwick; B. Robbins; C. Alvero; P. Palumbo; R. Yogev; J. Pinto; R. Hazra; M.L. Hughes; B.E. Heckman; et al.

Assessment of lopinavir pharmacokinetics with respect to developmental changes in infants and the impact on weight band-based dosing
Clinical Pharmacology and Therapeutics 2012;91(2):243-249.
117.
2012

Uriel Sandkovsky; Susan Swindells; Ryan Moore; Edward P. Acosta; Courtney V. Fletcher

Acceptable plasma concentrations of raltegravir and etravirine when administered by gastrostomy tube in a patient with advanced multidrug-resistant human immunodeficiency virus infection
Pharmacotherapy 2012;32(2):142-147.
118.
2012

Marilyn K. Speedie; Jeffrey N. Baldwin; Rodney A. Carter; Cynthia L. Raehl; Victor A. Yanchick; Lucinda L. Maine

Cultivating 'habits of mind' in the scholarly pharmacy clinician: Report of the 2011-12 Argus Commission
119.
2011

Obi C. Umeh; Judith S. Currier; Jeong-Gun Park; Yoninah Cramer; Ashwaq E. Hermes; Courtney V. Fletcher

Sex differences in lopinavir and ritonavir pharmacokinetics among HIV-infected women and men
Journal of Clinical Pharmacology 2011;51(12):1665-1673.
120.
2011

Patricia M. Flynn; Mark Mirochnick; David E. Shapiro; Arlene Bardeguez; John Rodman; Brian Robbins; Sharon Huang; Susan A. Fiscus; Koen K. A. Van Rompay; James F. Rooney; et al.

Pharmacokinetics and safety of single-dose tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant women and their infants
Antimicrobial Agents and Chemotherapy 2011;55(12):5914-5922.
121.
2011

M.L. Kelso; D.J. Liput; D.W. Eaves; K. Nixon

Upregulated vimentin suggests new areas of neurodegeneration in a model of an alcohol use disorder
Neuroscience 2011;197():381-393.
122.
2011

Diane E. Beck; Jeffrey N. Baldwin; Cynthia L. Raehl; Marilyn K. Speedie; Victor A. Yanchick; Robert A. Kerr

Roles of the pharmacy academy in informing consumers about the new American pharmacist: 2010-2011 Argus commission report
American Journal of Pharmaceutical Education 2011;75(10):30-.
123.
2011

James T. Lane; David E. Odegaard; Claire E. Haire; Dean S. Collier; Lucile E. Wrenshall; R. Brian Stevens

Sitagliptin therapy in kidney transplant recipients with new-onset diabetes after transplantation
Transplantation 2011;92(10):e56-e57.
124.
2010

Stephen W. Nissen; Keith M. Olsen

Treatment algorithms in critical care: Do they improve outcomes?
Journal of Pharmacy Practice 2010;23(1):61-68.
125.
2010

Tammy M. Winterboer; Kassandra A. Lecci; Keith M. Olsen

Alternative approaches to optimizing antimicrobial pharmacodynamics in critically ill patients
Journal of Pharmacy Practice 2010;23(1):6-18.
126.
2010

Keith M. Olsen; Tien M.H. Ng

Introduction: Infectious diseases in the critically ill
Journal of Pharmacy Practice 2010;23(1):5-.
127.
2010

Paul P. Dobesh; Stephanie M. Swahn; Evan J. Peterson; Keith M. Olsen

Statins in sepsis
Journal of Pharmacy Practice 2010;23(1):38-49.
128.
2010

Kena J Lanham; Julie H Oestreich; Steven P Dunn; Steven R Steinhubl

Impact of genetic polymorphisms on clinical response to antithrombotics
Pharmacogenomics and Personalized Medicine 2010;3(1):87-99.
129.
2009

Timothy McGuire; Paul Dobesh; Don Klepser; Mark Rupp; Keith Olsen

Clinically important interaction between statin drugs and Clostridium difficile toxin?
Medical Hypotheses 2009;73(6):1045-1047.
130.
2009

Jay P. Bae; Paul P. Dobesh; Patrick L. McCollam; Ali Khoynezhad

Potential unrecognised costs of clopidogrel pretreatment in acute coronary syndrome
Journal of Medical Economics 2009;12(4):325-330.
131.
2009

Paul P. Dobesh

Clopidogrel versus prasugrel: Times are changing, but not for everyone
Pharmacotherapy 2009;29(12):1393-1396.
132.
2009

Paul P Dobesh; Ann K Wittkowsky; Zachary Stacy; William E Dager; Toby C Trujillo; Michael P Gulseth; Edith Nutescu; Tom Vondracek

Key articles and guidelines in the treatment of venous thromboembolism.
Pharmacotherapy 2009;29(11):1385-.
133.
2009

Paul P. Dobesh

Pharmacokinetics and pharmacodynamics of prasugrel, a thienopyridine P2Y12 inhibitor
Pharmacotherapy 2009;29(9):1089-1102.
134.
2009

J. Oestreich

SCH-530348, a thrombin receptor (PAR-1) antagonist for the prevention and treatment of atherothrombosis
Current Opinion in Investigational Drugs 2009;10(9):988-996.
135.
2007

Paul P. Dobesh; Sara D. Brouse; William E. Dager; Sarah A. Spinler; Zachary Stacy; Barbara S. Wiggins

Key articles and guidelines in the management of acute coronary syndromes and in percutaneous coronary intervention: 2007 Update
Pharmacotherapy 2007;27(12 I):1722-1758.
136.
2007

Paul P. Dobesh; Toby C. Trujillo

Ranolazine: A new option in the management of chronic stable angina
Pharmacotherapy 2007;27(12 I):1659-1676.
137.
2007

Toby C. Trujillo; Paul P. Dobesh

Traditional management of chronic stable angina
Pharmacotherapy 2007;27(12 I):1677-1692.
138.
2007

Themba T. Ndovi; Ying-Jun Cao; Edward Fuchs; Courtney V. Fletcher; Anita Guidos; Craig W. Hendrix

Food affects zidovudine concentration independent of effects on gastrointestinal absorption
Journal of Clinical Pharmacology 2007;47(11):1366-1373.
139.
2007

Mark Mirochnick; J.H. Rodman; B.L. Robbins; A. Fridland; J. Gandía; J. Hitti; A. Bardeguez; M.H. Rathore; A. Gonzalez Garcia; et al.

Pharmacokinetics of oral zidovudine administered during labour: A preliminary study
HIV Medicine 2007;8(7):451-456.
140.
2007

David M. Margolis; A. Lisa Mukherjee; Courtney V. Fletcher; Evelyn Hogg; Debra Ogata-Arakaki; Tianna Petersen; David Rusin; Ana Martinez; John W. Mellors

The use of β-D-2,6-diaminopurine dioxolane with or without mycophenolate mofetil in drug-resistant HIV infection
AIDS 2007;21(15):2025-2032.
141.
2007

Gary L. Cochran; Katherine J. Jones; John Brockman; Anne Skinner; Rodney W. Hicks

USP medication safety forum: Errors prevented by and associated with bar-code medication administration systems
Joint Commission Journal on Quality and Patient Safety 2007;33(5):293-301.
142.
2007

Patricia M. Flynn; John Rodman; Jane C. Lindsey; Brian Robbins; Edmund Capparelli; Katherine M. Knapp; Jose F. Rodriguez; James McNamara; Leslie Serchuck; Barbara Heckman; et al.

Intracellular pharmacokinetics of once versus twice daily zidovudine and lamivudine in adolescents
Antimicrobial Agents and Chemotherapy 2007;51(10):3516-3522.
143.
2007

Peter L. Anderson; Jia-Hua Zheng; Tracy King; Lane R. Bushman; Julie Predhomme; Amie Meditz; John Gerber; Courtney V. Fletcher

Concentrations of zidovudine- and lamivudine-triphosphate according to cell type in HIV-seronegative adults
AIDS 2007;21(14):1849-1854.
144.
2007

Akihiko Saitoh; Courtney V. Fletcher; Richard Brundage; Carmelita Alvero; Terrence Fenton; Karen Hsia; Stephen A. Spector

Efavirenz pharmacokinetics in HIV-1-infected children are associated with CYP2B6-G516T polymorphism
Journal of Acquired Immune Deficiency Syndromes 2007;45(3):280-285.
145.
2007

Gilbert J Burckart; Daniel M Canafax; Gary C Yee

Cyclosporine monitoring. 1986.
The Annals of pharmacotherapy 2007;41(7):1277-1280.
146.
2007

Robert A. Kyle; Gary C. Yee; Mark R. Somerfield; Patrick J. Flynn; Susan Halabi; Sundar Jagannath; Robert Z. Orlowski; David G. Roodman; Patricia Twilde; Kenneth Anderson

ASCO 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma: Guideline summary
Journal of Oncology Practice 2007;3(4):236-.
147.
2007

Robert A. Kyle; Gary C. Yee; Mark R. Somerfield; Patrick J. Flynn; Susan Halabi; Sundar Jagannath; Robert Z. Orlowski; David G. Roodman; Patricia Twilde; Kenneth Anderson

American society of clinical oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma
Journal of Clinical Oncology 2007;25(17):2464-2472.
148.
2005

Jennifer R. King; John G. Gerber; Courtney V. Fletcher; Lane Bushman; Edward P. Acosta

Indinavir protein-free concentrations when used in indinavir/ritonavir combination therapy
AIDS 2005;19(10):1059-1063.
149.
2005

William R. Doucette; Randal P. McDonough; Donald Klepser; Renee McCarthy

Comprehensive medication therapy management: Identifying and resolving drug-related issues in a community pharmacy
Clinical Therapeutics 2005;27(7):1104-1111.
150.
2005

Keith M. Olsen

Pharmacologic agents associated with QT interval prolongation
Journal of Family Practice 2005;54(6 SUPPL.):S8-S14.
151.
2005

Sarah A. Spinler; Paul Dobesh

Dose capping enoxaparin is unjustified and denies patients with acute coronary syndromes a potentially effective treatment [9]
Chest 2005;127(6):2288-2289.
152.
2005

Keith M. Olsen

Use of acid-suppression therapy for treatment of non-variceal upper gastrointestinal bleeding
American Journal of Health-System Pharmacy 2005;62(SUPPL. 2):S18-S23.
153.
2005

Robin DiFrancesco; Diane T. Holland; Joanne E. Schiffhauer; Brian L. Robbins; Kelly M. Tooley; Gene D. Morse

A Quality Assurance Program for AIDS Clinical Trials Group Pharmacology Studies
Quality Assurance Journal 2005;9(1):22-30.
154.
2005

Elizabeth A. Chrischilles; Donald G. Klepser; John M. Brooks; Margaret D. Voelker; Shari S. Chen-Hardee; Shane D. Scott; Brian K. Link; David J. Delgado

Effect of clinical characteristics on neutropenia-related inpatient costs among newly diagnosed non-Hodgkin's lymphoma cases during first-course chemotherapy
Pharmacotherapy 2005;25(5 I):668-675.
155.
2005

Stephen I. Pelton; Kenneth Stanley; Ram Yogev; Courtney V. Fletcher; Kenneth McIntosh; Andrew Wiznia; Sharon Nachman

Switch from ritonavir to indinavir in combination therapy for HIV-1-infected children
Clinical Infectious Diseases 2005;40(8):1181-1187.
156.
2005

Katharine A. Reisbig; Pamela A. Coffman; Anthony A. Floreani; Christopher J. Bultsma; Keith M. Olsen

Staggered transition to epoprostenol from treprostinil in pulmonary arterial hypertension
Annals of Pharmacotherapy 2005;39(4):739-743.
157.
2005

Mike McGuire; Paul P. Dobesh

Erratum: Therapeutic update on the prevention and treatment of venous thromboembolism (Journal of Pharmacy Practice (October 2004) 17:5)
Journal of Pharmacy Practice 2005;18(2):132-.
158.
2005

Akihiko Saitoh; Kumud K. Singh; Christine A. Powell; Terrence Fenton; Courtney V. Fletcher; Richard Brundage; Stuart Starr; Stephen A. Spector

An MDR1-3435 variant is associated with higher plasma nelfinavir levels and more rapid virologic response in HIV-1 infected children
AIDS 2005;19(4):371-380.
159.
2005

Laurel C. Preheim; Keith M. Olsen; Mei Yue; Mary U. Snitily; Martha J. Gentry-Nielsen

Effect of cirrhosis on antibiotic efficacy in a rat model of pneumococcal pneumonia
Diagnostic Microbiology and Infectious Disease 2005;51(2):103-111.
160.
2004

Paul P. Dobesh; Zachary A. Stacy; Alexander J. Ansara; Jason M. Enders

Drug-eluting stents: A mechanical and pharmacologic approach to coronary artery disease
Pharmacotherapy 2004;24(11):1554-1577.
161.
2002

Laura A. Guay; Philippa Musoke; David L. Hom; Clemensia Nakabiito; Danstan Bagenda; Courtney V. Fletcher; Lawrence H. Marum; Mary Glenn Fowler; Lars G. Falksveden; et al.

Phase I/II trial of HIV-1 hyperimmune globulin for the prevention of HIV-1 vertical transmission in Uganda
AIDS 2002;16(10):1391-1400.
162.
2002

Akihiko Saitoh; Karen Hsia; Terence Fenton; Christine A. Powell; Cindy Christopherson; Courtney V. Fletcher; Stuart E. Starr; Stephen A. Spector

Persistence of human immunodeficiency virus (HIV) type 1 DNA in peripheral blood despite prolonged suppression of plasma HIV-1 RNA in children
Journal of Infectious Diseases 2002;185(10):1409-1416.
163.
2002

Courtney V. Fletcher; Peter L. Anderson; Thomas N. Kakuda; Timothy W. Schacker; Keith Henry; Cynthia R. Gross; Richard C. Brundage

Concentration-controlled compared with conventional antiretroviral therapy for HIV infection
AIDS 2002;16(4):551-560.
164.
2002

Stuart E. Starr; Courtney V. Fletcher; Stephen A. Spector; Richard C. Brundage; Florence H. Yong; Steven D. Douglas; Patrizia M. Flynn; Mark W. Kline

Efavirenz liquid formulation in human immunodeficiency virus-infected children
Pediatric Infectious Disease Journal 2002;21(7):659-663.
165.
2002

Michael E. Klepser; Donald G. Klepser

The dynamics of health care resource utilization
Pharmacotherapy 2002;22(2 II):39S-44S.
166.
2002

David J. Back; Giorgio Gatti; Courtney Fletcher; Rodolphe Garaffo; Richard Haubrich; Richard Hoetelmans; Michael Kurowski; Andrew Luber; Concepta Merry; Carlo-Federico Perno

Therapeutic drug monitoring in HIV infection: Current status and future directions
AIDS, Supplement 2002;16(1):S5-S37.
167.
2002

Donald G. Klepser

Pitfalls associated with commonly used methods for pharmacoeconomic analyses
Pharmacotherapy 2002;22(2 II):35S-38S.
168.
2002

Sibylle Grub; Patricia DeLora; Eric Lüdin; Frank Duff; Courtney V. Fletcher; Richard C. Brundage; Mark W. Kline; Nancy R. Calles; Heidi Schwarzwald; et al.

Pharmacokinetics and pharmacodynamics of saquinavir in pediatric patients with human immunodeficiency virus infection
Clinical Pharmacology and Therapeutics 2002;71(3):122-130.
169.
2002

Keith M. Olsen

Medication errors: Problems identified, but what is the solution?
Critical Care Medicine 2002;30(4):944-945.
170.
2002

Peter L. Anderson; Richard C. Brundage; Thomas N. Kakuda; Courtney V. Fletcher

CD4 response is correlated with peak plasma concentrations of indinavir in adults with undetectable human immunodeficiency virus ribonucleic acid
Clinical Pharmacology and Therapeutics 2002;71(4):280-285.
171.
2002

Heather E. Wynn; Richard C. Brundage; Courtney V. Fletcher

Clinical implications of CNS penetration of antiretroviral drugs
CNS Drugs 2002;16(9):595-609.
172.
2002

Martha J. Gentry-Nielsen; Keith M. Olsen; Laurel C. Preheim

Pharmacodynamic activity and efficacy of linezolid in a rat model of pneumococcal pneumonia
Antimicrobial Agents and Chemotherapy 2002;46(5):1345-1351.
173.
2002

S. Horslen; C. Torres; D. Collier; K. Iyer; D. Sudan; B. Shaw; A. Langas

Initial experience using rapamycin immunosuppression in pediatric intestinal transplant recipients
Transplantation Proceedings 2002;34(3):934-935.
174.
1999

Courtney V. Fletcher

Pharmacologic considerations for therapeutic success with antiretroviral agents
Annals of Pharmacotherapy 1999;33(9):989-995.
175.
1999

Tom E. Peddicord; Keith M. Olsen; Dean S. Collier

Effect of omeprazole, lansoprazole, and ranitidine on the dna synthesis of mononuclear cells
Critical Care Medicine 1999;27(1):90-94.
176.
1999

Edward P. Acosta; Keith Henry; Leslie Baken; Linda M. Page; Courtney V. Fletcher

Indinavir concentrations and antiviral effect
Pharmacotherapy 1999;19(6):708-712.
177.
1999

John R. Wingard; Paul Kubilis; Lily Lee; Gary Yee; Mary White; Louise Walshe; Raleigh Bowden; Elias Anaissie; John Hiemenz; John Lister

Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis
Clinical Infectious Diseases 1999;29(6):1402-1407.
178.
1999

Jeffrey K. Low; Jeffrey N. Baldwin; Gary E. Greiner

Pediatric pharmacy education for U.S. entry-level doctor of pharmacy programs
American Journal of Pharmaceutical Education 1999;63(3):323-327.
179.
1999

Jill A. Rebuck; Gary C. Yee; Tom E. Peddicord; Casey Nelson; Gary L. Cochran; Keith M. Olsen

Thrombocytopenia-associated costs in an adult intensive care unit population
Critical Care Medicine 1999;27(12 SUPPL.):A47.
180.
1999

Kimberly L. Bergman; Stuart Kaufman; Dean Collier; Jill A. Rebuck; Cindy Brown; Keith M. Olsen

Pharmacodynamics of omeprazole suspension in critically ill pediatric liver/intestinal transplant patients
Critical Care Medicine 1999;27(1 SUPPL.):A171.
181.
1998

T.N. Kakuda; E.P. Acosta; C.V. Fletcher

Potential confusion with antiretroviral drugs
American Journal of Health-System Pharmacy 1998;55(24):2639-2640.
182.
1998

Brian L. Robbins; Thu T. Tran; Frank H. Pinkerton Jr.; Fatima Akeb; Roger Guedj; Jacques Grassi; Danny Lancaster; Arnold Fridland

Development of a new cartridge radioimmunoassay for determination of intracellular levels of lamivudine triphosphate in the peripheral blood mononuclear cells of human immunodeficiency virus-infected patients
Antimicrobial Agents and Chemotherapy 1998;42(10):2656-2660.
183.
1998

Courtney V. Fletcher; Edward P. Acosta; Keith Henry; Linda M. Page; Cynthia R. Gross; Sagar P. Kawle; Rory P. Remmel; Alejo Erice; Henry H. Balfour Jr.

Concentration-controlled zidovudine therapy
Clinical Pharmacology and Therapeutics 1998;64(3):331-338.
184.
1998

Jeffrey N. Baldwin; James W. Alexander; Ernest J. Dole; Gae Ryan; Fred C. Hirning

ASHP statement on the pharmacist's role in substance abuse prevention, education, and assistance
American Journal of Health-System Pharmacy 1998;55(16):1721-1724.
185.
1993

T.R. McGuire; W.A. Narducci; J.L. Fox

Compatibility and stability of ondansetron hydrochloride, dexamethasone, and lorazepam in injectable solutions
American Journal of Hospital Pharmacy 1993;50(7):1410-1414.
186.
1993

M.S. Shaefer; D.S. Collier; M.C. Haven; A.N. Langnas; R.J. Stratta; J.P. Donovan; M.F. Sorrell; B.W. Shaw Jr.

Falsely elevated FK-506 levels caused by sampling through central venous catheters
Transplantation 1993;56(2):475-476.
187.
1993

G.D. Campbell; S. Ramaprasad; K.M. Olsen; A.F. Tryka; R.A. Komoroski; L.C. Blaszczak; T.R. Parr Jr.

Comparison of the in vivo and in vitro nuclear magnetic resonance detection of trifluoromethyl penicillin V in rats
Journal of Pharmaceutical Sciences 1993;82(1):48-51.
188.
1993

K.M. Olsen; F.H. Ma; B.H. Ackerman; R.E. Stull

Low-volume whole bowel irrigation and salicylate absorption: A comparison with ipecac-charcoal
Pharmacotherapy 1993;13(3):229-232.
189.
1993

K.M. Olsen; B.J. Gurley; G.A. Davis; R. Christensen; M.S. Monaghan

Stability of flumazenil with selected drugs in 5% dextrose injection
American Journal of Hospital Pharmacy 1993;50(9):1907-1912.
190.
1993

M.S. Shaefer; D.S. Collier

Immunosuppression for solid organ transplantation
Dialysis and Transplantation 1993;22(9):542-543+546+548+550+552-553+571.
191.
1993

C.V. Fletcher

Current perspectives on antiretroviral therapy
Pharmacotherapy 1993;13(6 I):627-633.
192.
1993

R.V. Srinivas; B.L. Robbins; M.C. Connelly; Y.-F. Gong; N. Bischofberger; A. Fridland

Metabolism and in vitro antiretroviral activities of bis(pivaloyloxymethyl) prodrugs of acyclic nucleoside phosphonates
Antimicrobial Agents and Chemotherapy 1993;37(10):2247-2250.
193.
1993

S.G. Burch; L.P. Gann; K.M. Olsen; P.J. Anderson; F.C. Hiller; M.L. Erbland

Effect of pH on nicotine absorption and side effects produced by aerosolized nicotine
Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung 1993;6(1):45-52.
194.
1993

M.S. Monaghan; B.H. Ackerman; K.M. Olsen; C. Farmer; A.A. Pappas

The use of Δ osmolality to predict serum isopropanol and acetone concentrations
Pharmacotherapy 1993;13(1):60-63.
195.
1993

G.C. Yee; M.L. Levinson; P.A. Jacobson

Treatment and prophylaxis of cytomegalovirus disease: A commentary
Pharmacotherapy 1993;13(2 I):167-168.
196.
1993

J.B. Cone; B.H. Wallace; K.M. Olsen; F.T. Caldwell Jr.; B.J. Gurley; P.J. Bond

The pharmacokinetics of ibuprofen after burn injury
Journal of Burn Care and Rehabilitation 1993;14(6):666-669.
197.
1993

C.V. Fletcher; E.P. Acosta

Advances in pharmacotherapy: Treatment of HIV infection
Journal of Clinical Pharmacy and Therapeutics 1993;18(6):375-388.
198.
1992

G.C. Yee; R.S. Weiner

Recent advances in bone marrow transplantation. Introduction.
Seminars in Oncology 1992;19(3 Suppl 7):1-2.
199.
1992

Janet A. Englund; Courtney V. Fletcher; Henry H. Balfour Jr.

Reply
The Journal of Pediatrics 1992;120(4 PART 1):665-.
200.
1992

C.V. Fletcher; F.S. Rhame; C.C. Beatty; M. Simpson; H.H. Balfour Jr.

Comparative pharmacokinetics of zidovudine in healthy volunteers and in patients with AIDS with and without hepatic disease
Pharmacotherapy 1992;12(6 I):429-434.
201.
1992

S.P. Smith; G.C. Yee

Hematopoiesis
Pharmacotherapy 1992;12(2 II):11S-19S.
202.
1992

J. Kavaliotis; J.A. Englund; C.V. Fletcher; H.H. Balfour Jr.

Acyclovir therapy in neonates [8]
Journal of Pediatrics 1992;120(4 I):665-.
203.
1992

H.L. McLeod; T.R. McGuire; G.C. Yee

Stability of cyclosporine in dextrose 5%, NaCl 0.9%, dextrose/amino acid solution, and lipid emulsion
Annals of Pharmacotherapy 1992;26(2):172-175.
204.
1992

S.D. Goodwin; C.V. Fletcher

Introduction to the 'HIV and AIDS' column
Annals of Pharmacotherapy 1992;26(5):700-.
205.
2011

Sonal R. Tuljapurkar; Timothy R. Mcguire; Susan K. Brusnahan; John D. Jackson; Kevin L. Garvin; Margaret A. Kessinger; Judy T. Lane; Barbara J. O'Kane; John G. Sharp

Changes in human bone marrow fat content associated with changes in hematopoietic stem cell numbers and cytokine levels with aging
Journal of Anatomy 2011;219(5):574-581.
206.
2011

Julie H. Oestreich

Progress of antiplatelet pharmacogenomics
Current Drug Targets 2011;12(12):1848-1858.
207.
2011

Gautam Baheti; Jennifer J. Kiser; Peter L. Havens; Courtney V. Fletcher

Plasma and intracellular population pharmacokinetic analysis of tenofovir in HIV-1-infected patients
Antimicrobial Agents and Chemotherapy 2011;55(11):5294-5299.
208.
2011

Julie H. Oestreich; Steven R. Steinhubl; Suellen P. Ferraris; Wendell S. Akers

High residual platelet reactivity on standard clopidogrel maintenance dose predicts increased responsiveness to the doublestandard dose in an assay-dependent manner
Thrombosis and Haemostasis 2011;105(5):927-930.
209.
2011

Timothy R. McGuire; Susan K. Brusnahan; Laura D. Bilek; John D. Jackson; M. Anne Kessinger; Anne M. Berger; Kevin L. Garvin; Barbara J. O'Kane; Sonal R. Tuljapurkar; John G. Sharp

Inflammation associated with obesity: Relationship with blood and bone marrow endothelial cells
Obesity 2011;19(11):2130-2136.
210.
1993

M.S. Monaghan; B.H. Ackerman; K.M. Olsen; C. Farmer; A.A. Pappas

Erratum: The use of Δ osmolality to predict serum isopropanol and acetone concentrations (Pharmacotherapy (1993) 13 (60-63))
Pharmacotherapy 1993;13(2 I):P-8.
211.
2011

Thomas Boulet; Matthew L. Kelso; Shadi F. Othman

Microscopic magnetic resonance elastography of traumatic brain injury model
Journal of Neuroscience Methods 2011;201(2):296-306.
212.
2011

Catherine H. Van Poznak; William E. Barlow; J. Sybil Biermann; Linda D. Bosserman; Cindy Geoghegan; Bruce E. Hillner; Nora A. Janjan; Sarah Temin; Richard L. Theriault; Gary C. Yee; et al.

Reply to J.R. Gralow et al
Journal of Clinical Oncology 2011;29(26):3592-3593.
213.
2011

Susan Swindells; Charles Flexner; Courtney V. Fletcher; Jeffrey M. Jacobson

The critical need for alternative antiretroviral formulations, and obstacles to their development
Journal of Infectious Diseases 2011;204(5):669-674.
214.
2011

Zachary A. Stacy; Paul P. Dobesh; Toby C. Trujillo; William E. Dager; Toni Ripley; Kari L. Olson

Key articles and guidelines in the management of peripheral arterial disease
Pharmacotherapy 2011;31(9):176e-206e.
215.
2011

Michael B. Streiff; Paula L. Bockenstedt; Spero R. Cataland; Carolyn Chesney; Charles Eby; John Fanikos; Patrick F. Fogarty; Shuwei Gao; Julio Garcia-Aguilar; Samuel Z. Goldhaber; et al.

Venous thromboembolic disease: Clinical practice guidelines in oncology
JNCCN Journal of the National Comprehensive Cancer Network 2011;9(7):714-777.
216.
2011

Jennifer J. Kiser; Richard M. Rutstein; Pearl Samson; Bobbie Graham; Grace Aldrovandi; Lynne M. Mofenson; Elizabeth Smith; Steven Schnittman; Terry Fenton; Richard C. Brundage; et al.

Atazanavir and atazanavir/ritonavir pharmacokinetics in HIV-infected infants, children, and adolescents
AIDS 2011;25(12):1489-1496.
217.
2011

Catherine H. Van Poznak; Sarah Temin; Gary C. Yee; Nora A. Janjan; William E. Barlow; J. Sybil Biermann; Linda D. Bosserman; Cindy Geoghegan; Bruce E. Hillner; Richard L. Theriault; et al.

American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer
Journal of Clinical Oncology 2011;29(9):1221-1227.
218.
2011

Ellen G. Chadwick; Ram Yogev; Carmelita G. Alvero; Michael D. Hughes; Rohan Hazra; Jorge A. Pinto; Brian L. Robbins; Barbara E. Heckman; Paul E. Palumbo; Edmund V. Capparelli

Long-term outcomes for HIV-infected infants less than 6 months of age at initiation of lopinavir/ritonavir combination antiretroviral therapy
AIDS 2011;25(5):643-649.
219.
2009

Jayashri Sankaranarayanan; Shinobu Watanabe-Galloway; Junfeng Sun; Fang Qiu; Eugene Boilesen; Alan G. Thorson

Rurality and other determinants of early colorectal cancer diagnosis in nebraska: A 6-year cancer registry study, 1998-2003
Journal of Rural Health 2009;25(4):358-365.
220.
2009

Paul P. Dobesh

Economic burden of venous thromboembolism in hospitalized patients
Pharmacotherapy 2009;29(8):943-953.
221.
2009

Tom Delahunty; Lane Bushman; Brian Robbins; Courtney V. Fletcher

The simultaneous assay of tenofovir and emtricitabine in plasma using LC/MS/MS and isotopically labeled internal standards
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 2009;877(20-21):1907-1914.
222.
2009

Ruth Margalit; Sarah Thompson; Constance Visovsky; Jenenne Geske; Dean Collier; Thomas Birk; Paul Paulman

From professional silos to interprofessional education: Campuswide focus on quality of care
Quality Management in Health Care 2009;18(3):165-173.
223.
2009

Jeffrey N. Baldwin; Jean K. Bartek; David M. Scott; R. Ellen Davis-Hall; Edward M. Desimone Ii

Survey of alcohol and other drug use attitudes and behaviors in nursing students
Substance Abuse 2009;30(3):230-238.
224.
2009

Paul P. Dobesh; Donald G. Klepser; Timothy R. McGuire; Craig W. Morgan; Keith M. Olsen

Reduction in mortality associated with statin therapy in patients with severe sepsis
Pharmacotherapy 2009;29(6):621-630.
225.
2009

Paul P. Dobesh; Zachary A. Stacy; Emily L. Persson

Pharmacologic therapy for intermittent claudication
Pharmacotherapy 2009;29(5):526-553.
226.
2009

J.W. Sleasman; B.L. Robbins; S.J. Cross; J.C. Lindsey; J.M. Kraimer; B.E. Heckman; H.L. Sprenger; N.B. Tustin; C.H. Rose; et al.

Abacavir pharmacokinetics during chronic therapy in HIV-1-infected adolescents and young adults
Clinical Pharmacology and Therapeutics 2009;85(4):394-401.
227.
2009

Julie H. Oestreich; John Holt; Steven P. Dunn; Susan S. Smyth; Charles L. Campbell; Richard Charnigo; Wendell S. Akers; Steven R. Steinhubl

Considerable variability in platelet activity among patients with coronary artery disease in response to an increased maintenance dose of clopidogrel
Coronary Artery Disease 2009;20(3):207-213.
228.
2009

Courtney V. Fletcher

Antiretroviral drug-drug interaction considerations for HIV-infected children
Pediatric Infectious Disease Journal 2009;28(5):429-430.
229.
2009

Shane J. Cross; John H. Rodman; Jane C. Lindsey; Brian L. Robbins; Charles H. Rose; Geoffrey J. Yuen; Lawrence J. D'Angelo

Abacavir and metabolite pharmacokinetics in hiv-1-infected children and adolescents
Journal of Acquired Immune Deficiency Syndromes 2009;51(1):54-59.
230.
2007

John M. Brooks; Donald G. Klepser; Julie M. Urmie; Karen B. Farris; William R. Doucette

Effect of local competition on the willingness of community pharmacies to supply medication therapy management services
Journal of Health and Human Services Administration 2007;30(1):4-27.
231.
2007

Brian L. Robbins; Philip A. Poston; Erin F. Neal; Clive Slaughter; John H. Rodman

Simultaneous measurement of intracellular triphosphate metabolites of zidovudine, lamivudine and abacavir (carbovir) in human peripheral blood mononuclear cells by combined anion exchange solid phase extraction and LC-MS/MS
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 2007;850(1-2):310-317.
232.
2007

Jayashri Sankaranarayanan; Susan E. Puumala

Epidemiology and characteristics of emergency departments visits by US adults with psychiatric disorder and antipsychotic mention from 2000 to 2004
Current Medical Research and Opinion 2007;23(6):1375-1385.
233.
2007

Ann M. Berger; Jayashri Sankaranarayanan; Shinobu Wanatabe-Galloway

Current methodological approaches to the study of sleep disturbances and quality of life in adults with cancer: A systematic review
Psycho-Oncology 2007;16(5):401-420.
234.
2007

Sandra L. Kane-Gill; Keith M. Olsen; Jill A. Rebuck; Rhonda S. Rea; D. Wesston Boatwright; Maureen A. Smythe; Terrence R. Walker; Stephanie L. Lager; Tudy Hodgman

Multicenter treatment and outcome evaluation of aspiration syndromes in critically ill patients
Annals of Pharmacotherapy 2007;41(4):549-555.
235.
2007

Jayashri Sankaranarayanan; Susan E. Puumala

Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the united states, 1996-2003: National estimates and associated factors
Clinical Therapeutics 2007;29(4):723-741.
236.
2007

Courtney V. Fletcher; Jaime G. DeVille; Pearl M. Samson; John H. Moye Jr.; Joseph A. Church; Hans M.L. Spiegel; Paul Palumbo; Terence Fenton; M. Elizabeth Smith; Bobbie Graham; et al.

Nonlinear pharmacokinetics of high-dose recombinant fusion protein CD4-IgG2 (PRO 542) observed in HIV-1-infected children
Journal of Allergy and Clinical Immunology 2007;119(3):747-750.
237.
2007

Richard H. Haubrich; Hongyu Jiang; Ronald Swanstrom; Michael Bates; David Katzenstein; Leslie Petch; Courtney V. Fletcher; Susan A. Fiscus; Roy M. Gulick

Non-nucleoside phenotypic hypersusceptibility cut-point determination from ACTG 359
HIV Clinical Trials 2007;8(2):63-67.
238.
2007

Timothy R. McGuire; Melissa Leypoldt; Warren A. Narducci; Kathy Ward

Accessing rural populations: Role of the community pharmacist in a breast and cervical cancer screening programme
Journal of Evaluation in Clinical Practice 2007;13(1):146-149.
239.
2007

G.W. Hogeland; S. Swindells; J.C. McNabb; A.D.M. Kashuba; G.C. Yee; C.M. Lindley

Lopinavir/ritonavir reduces bupropion plasma concentrations in healthy subjects
Clinical Pharmacology and Therapeutics 2007;81(1):69-75.
240.
2007

Timothy R. McGuire; David M. Scott; Samuel C. Augustine; Yen Nyugen; Kathy Ward; Melissa Leybold; Michelle Heffelfinger

Impact of prescription drug expense on low-income women with hypertension, dyslipidemia, and diabetes in the state of Nebraska
Clinical Research and Regulatory Affairs 2007;24(1):49-59.
241.
2007

Courtney V. Fletcher

Translating efficacy into effectiveness in antiretroviral therapy: Beyond the pill count
Drugs 2007;67(14):1969-1979.
242.
2007

Stephen W. Nissen; Keith M. Olsen

Selection of proton pump inhibitors for formulary inclusion: Making decisions based on appropriate criteria
Disease Management and Health Outcomes 2007;15(5):289-298.
243.
2007

Robert A. Blouin; Richard F. Bergstrom; Vicki L. Ellingrod; Courtney V. Fletcher; Richard D. Leff; Andrew Morris; Richard T. Okita; Jeanette C. Roberts; Timothy S. Tracy; Rosalie Sagraves; et al.

Report of the AACP Educating Clinical Scientists Task Force
244.
2005

Randy P. McDonough; William R. Doucette; Patty Kumbera; Donald G. Klepser

An evaluation of managing and educating patients on the risk of glucocorticoid-induced osteoporosis
Value in Health 2005;8(1):24-31.
245.
2005

Marta Boffito; Edward Acosta; David Burger; Courtney V. Fletcher; Charles Flexner; Rodolphe Garaffo; Giorgio Gatti; Michael Kurowski; Carlo Federico Perno; et al.

Current status and future prospects of therapeutic drug monitoring and applied clinical pharmacology in antiretroviral therapy
Antiviral Therapy 2005;10(3):375-392.
246.
2005

Marta Boffito; Edward Acosta; David Burger; Courtney V. Fletcher; Charles Flexner; Rodolphe Garaffo; Giorgio Gatti; Michael Kurowski; Carlo Federico Perno; et al.

Therapeutic drug monitoring and drug-drug interactions involving antiretroviral drugs
Antiviral Therapy 2005;10(4):469-477.
247.
2004

Karen B. Farris; Julie M. Ganther-Urmie; Gang Fang; William R. Doucette; John M. Brooks; Donald G. Klepser; David J. Fries; Carol L. Kuhle

Population-based medication reviews: A descriptive analysis of the medication issues identified in a medicare not-for-profit prescription discount program
Annals of Pharmacotherapy 2004;38(11):1823-1829.
248.
2004

Paul P. Dobesh

Ximelagatran: Pharmacology, pharmacokinetics, and pharmacodynamics
Pharmacotherapy 2004;24(10 I):169S-178S.
249.
2004

Paul P. Dobesh; Karissa Kim; Zachary Stacy

The future of anticoagulation
Journal of Pharmacy Practice 2004;17(5):370-384.
250.
2004

Eric Brian Hoie; Timothy Robert McGuire; Patricia Mary Leuschen; Terrence Leo Zach

Pentoxifylline inhibits tumor necrosis factor-alpha induced synthesis of complement component C3 in human endothelial cells
Biological and Pharmaceutical Bulletin 2004;27(10):1670-1673.
251.
2004

Ronald Swanstrom; Ronald J. Bosch; David Katzenstein; Hailong Cheng; Hongyu Jiang; Nicholas Hellmann; Richard Haubrich; Susan A. Fiscus; Courtney V. Fletcher; Edward P. Acosta; et al.

Weighted phenotypic susceptibility scores are predictive of the HIV-1 RNA response in protease inhibitor-experienced HIV-1-infected subjects
Journal of Infectious Diseases 2004;190(5):886-893.
252.
2004

Katherine J. Jones; Gary Cochran; Rodney W. Hicks; Keith J. Mueller

Translating research into practice: Voluntary reporting of medication errors in critical access hospitals
Journal of Rural Health 2004;20(4):335-343.
253.
2004

David J. Kroll; Ron Barnes; Carol J. Bickford; Lisa Boothby; Cindi Brennan; Sian Carr-Lopez; Steven Chen; Kevin J. Colgan; David Copelan; Joseph Cranston; et al.

ASHP statement on the use of dietary supplements
American Journal of Health-System Pharmacy 2004;61(16):1707-1711.
254.
2004

Paul P. Dobesh

Unfractionated heparin dosing nomograms: Road maps to where?
Pharmacotherapy 2004;24(8 II):142S-145S.
255.
2004

Paul P. Dobesh

Economics of unfractionated heparin: Beyond acquisition cost
Pharmacotherapy 2004;24(8 II):161S-164S.
256.
2002

Carl L Nelson; Sandra G McLaren; Robert A Skinner; Mark S Smeltzer; J. Roby Thomas; Keith M Olsen

The treatment of experimental osteomyelitis by surgical debridement and the implantation of calcium sulfate tobramycin pellets
Journal of Orthopaedic Research 2002;20(4):643-647.
257.
2002

Edward P. Acosta; Courtney V. Fletcher; Charles Flexner; David Haas; Stephen Hall; Fayez Hamzeh; Richard Haubrich; Angela Kashuba; David Katzenstein; Jody Lawrence; et al.

Position paper on therapeutic drug monitoring of antiretroviral agents
AIDS Research and Human Retroviruses 2002;18(12):825-834.
258.
2002

Jg Sharp; Tr McGuire; Sl Mann; B. Murphy; A. Kessinger

Plasma from poorly mobilizing human subjects inhibits cytokine-induced murine blood stem-cell mobilization
Cytotherapy 2002;4(4):365-373.
259.
2002

Stuart S. Kaufman; Elizabeth Ruby Lyden; Cindy R. Brown; Carolyn K. Davis; Deborah A. Andersen; Keith M. Olsen; Kimberly L. Bergman; Simon P. Horslen; Debra L. Sudan; Ira J. Fox; et al.

Omeprozole therapy in pediatric patients after liver and intestinal transplantation
Journal of Pediatric Gastroenterology and Nutrition 2002;34(2):194-198.
260.
2001

Michael S. Monaghan; Michael A. Marx; Keith M. Olsen; Paul D. Turner; Kimberly L. Bergman

Correlation and prediction of phenytoin protein binding using standard laboratory parameters in patients after renal transplantation
Therapeutic Drug Monitoring 2001;23(3):263-267.
261.
2001

J.N. Baldwin; E.D. Thibault

Substance abuse by pharmacists: stopping the insanity.
Journal of the American Pharmaceutical Association (Washington,D.C. : 1996) 2001;41(3):373-375.
262.
2001

J.N. Baldwin

Self-medication by pharmacists: familiarity breeds attempt?
Journal of the American Pharmaceutical Association (Washington,D.C. : 1996) 2001;41(3):371-.
263.
2001

K.M. Olsen; J.A. Rebuck; M.E. Rupp

Arthralgias and myalgias related to quinupristin-dalfopristin administration.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32(4):e83-86.
264.
2001

J.H.S. You; K.K.C. Lee; S.S.S. Ho; J.J.Y. Sung; N.N.S. Kung; M. Yung; C. Lee; G.C. Yee

Economic analysis off our triple regimens for the treatment of Helicobacter pylori-related peptic ulcer disease in in-patient and out-patient settings in Hong Kong
Alimentary Pharmacology and Therapeutics 2001;15(7):1009-1015.
265.
2001

E.-J.A. Yeoh; J.M. Cunningham; G.C. Yee; D. Hunt; J.A. Houston; S.L. Richardson; C.F. Stewart; P.J. Houghton; L.C. Bowman; A.J. Gajjar

Topotecan-filgrastim combination is an effective regimen for mobilizing peripheral blood stem cells
Bone Marrow Transplantation 2001;28(6):563-571.
266.
2001

Mark W. Kline; Richard C. Brundage; Courtney V. Fletcher; Heidi Schwarzwald; Nancy R. Calles; Neil E. Buss; Paul Snell; Patricia Delora; Monica Eason; et al.

Combination therapy with saquinavir soft gelatin capsules in children with human immunodeficiency virus infection
Pediatric Infectious Disease Journal 2001;20(7):666-671.
267.
1998

Paul P. Dobesh; Keith A. Latham

Advancing the battle against acute ischemic syndromes: A focus on the GP IIb-IIIa inhibitors
Pharmacotherapy 1998;18(4):663-685.
268.
1998

Konstantine K. Manouilov; Timothy R. McGuire; Peter R. Gwilt

Colorimetric determination of hydroxyurea in human serum using high- performance liquid chromatography
Journal of Chromatography B: Biomedical Applications 1998;708(1-2):321-324.
269.
1998

Konstantine K. Manouilov; Timothy R. McGuire; Bruce G. Gordon; Peter R. Gwilt

Assay for etoposide in human serum using solid-phase extraction and high-performance liquid chromatography with fluorescence detection
Journal of Chromatography B: Biomedical Applications 1998;707(1-2):342-346.
270.
1998

Brian L. Robbins; Ranga V. Srinivas; Choung Kim; Norbert Bischofberger; Arnold Fridland

Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2- phosphonomethoxypropyl)adenine (PMPA), bis(isopropyloxymethylcarbonyl)PMPA
Antimicrobial Agents and Chemotherapy 1998;42(3):612-617.
271.
1998

J.W. Hui; G.C. Yee

Pharmacoeconomics of biotechnology drugs (2).
Journal of the American Pharmaceutical Association (Washington,D.C. : 1996) 1998;38(2):231-233.
272.
1998

Jeffrey O. Phillips; Mchael H. Metzter; Roger E. Hucldeldt; Keith Olsen

A multicenter, prospective, randomized clinical tual of continuous infusion i.V. Ranitidine vs. omeprazdle suspension in the prophylaxis of stress ulcers
Critical Care Medicine 1998;26(1 SUPPL.):A101.
273.
1998

G.C. Yee

The clinical and economic rationale for peripheral blood progenitor cell transplantation. Introduction.
Pharmacotherapy 1998;18(1 Pt 2):1S-2S.
274.
1998

S.E. Beltz; G.C. Yee

Pharmacoeconomics of cancer therapy
Cancer Control 1998;5(5):415-424.
275.
1998

M.W. Kline; C.V. Fletcher; A.T. Harris; K.D. Evans; R.C. Brundage; R.P. Remmel; N.R. Calles; S.B. Kirkpatrick; C. Simon

A pilot study of combination therapy with indinavir, stavudine (d4T), and didanosine (ddI) in children infected with the human immunodeficiency virus
Journal of Pediatrics 1998;132(3 I):543-546.
276.
1998

G.C. Yee

Peripheral blood progenitor cell transplantation: Economic issues
Pharmacotherapy 1998;18(1):9S-16S.
277.
1998

T.R. McGuire; S. Tarantolo; E. Reed

Peripheral blood progenitor cells: Enabling outpatient transplantation
Pharmacotherapy 1998;18(1):17S-23S.
278.
1998

Thomas M. Attard; Anil Dhawan; Stuart S. Kaufman; Dean S. Collier; Alan N. Langnas

Use of disodium pamidronate in children with hypercalcemia awaiting liver transplantation
Pediatric Transplantation 1998;2(2):157-159.
279.
1997

Frederick M. Weeks; Gary C. Yee; Alison A. Bartfield; John R. Wingard

The true cost of bone marrow transplantation
American Journal of the Medical Sciences 1997;314(2):101-112.
280.
1997

Courtney V. Fletcher; Brian K. Goodroad; Larry M. Cummins; Keith Henry; Henry H. Balfour Jr.; Frank S. Rhame

Pharmacokinetics of hyperimmune anti-human immunodeficiency virus immunoglobulin in persons with AIDS
Antimicrobial Agents and Chemotherapy 1997;41(7):1571-1574.
281.
1997

Tom E. Peddicord; Keith M. Olsen; Troy L. Zumbrunnen; David J. Warner; Lauren Webb

Stability of high-concentration dopamine hydrochloride, norepinephrine bitartrate, epinephrine hydrochloride, and nitroglycerin in 5% dextrose injection
American Journal of Health-System Pharmacy 1997;54(12):1417-1419.
282.
1997

Edward P. Acosta; Keith Henry; Linda M. Page; Alejo Erice; Henry H. Balfour Jr.; Courtney V. Fletcher

Pharmacokinetics and safety of concentration-controlled oral zidovudine therapy
Pharmacotherapy 1997;17(3):424-430.
283.
1997

Edward P. Acosta; Courtney V. Fletcher

Valacyclovir
Annals of Pharmacotherapy 1997;31(2):185-191.
284.
1997

Gary C. Yee

Cost-utility analysis of taxane therapy
American Journal of Health-System Pharmacy 1997;54(SUPPL. 2):S11-S15.
285.
1997

J.S. Lambert; L.M. Mofenson; C.V. Fletcher; Jr. Moye J.; E.R. Stiehm; W.A. Meyer III; G.J. Nemo; B.J. Mathieson; G. Hirsch; C.V. Sapan; et al.

Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns
Journal of Infectious Diseases 1997;175(2):283-291.
286.
1992

T.R. McGuire; G.C. Yee; S. Emerson; D.J. Gmur; J. Carlin

Pharmacodynamic studies of cyclosporine in marrow transplant recipients: A comparison of three assay methods
Transplantation 1992;53(6):1272-1275.
287.
1992

C.V. Fletcher

Treatment of herpesvirus infections in HIV-infected individuals
Annals of Pharmacotherapy 1992;26(7-8):955-962.
288.
1992

G.C. Yee; R.S. Weiner

Introduction
Seminars in Oncology 1992;19(3 SUPPL. 7):1-2.
289.
1992

C.V. Fletcher

The placental transport and use of acyclovir in pregnancy
Journal of Laboratory and Clinical Medicine 1992;120(6):821-822.
290.
1992

D.R. Herrmann; K.M. Olsen; F.C. Hiller

Nicotine absorption after pulmonary instillation
Journal of Pharmaceutical Sciences 1992;81(11):1055-1058.
291.
1991

J.A. Englund; C.V. Fletcher; H.H. Balfour Jr.

Acyclovir therapy in neonates
Journal of Pediatrics 1991;119(1 I):129-135.
292.
1991

H.H. Balfour Jr.; C.V. Fletcher; D. Dunn

Prevention of cytomegalovirus disease with oral acyclovir
Transplantation Proceedings 1991;23(2 SUPPL. 1):17-19.
293.
1991

C.V. Fletcher; J.A. Englund; C.K. Edelman; C.R. Gross; D.L. Dunn; H.H. Balfour Jr.

Pharmacologic basis for high-dose oral acyclovir prophylaxis of cytomegalovirus disease in renal allograft recipients
Antimicrobial Agents and Chemotherapy 1991;35(5):938-943.
294.
1991

K.M. Olsen; G.D. Campbell Jr.

E5 monoclonal immunoglobulin M antibody for the treatment of gram-negative sepsis
DICP, Annals of Pharmacotherapy 1991;25(7-8):784-790.
295.
1991

B.H. Ackerman; K.M. Olsen; A.A. Pappas

Accumulation of 3-hydroxyquinidine following chronic quinidine therapy [2]
DICP, Annals of Pharmacotherapy 1991;25(7-8):867-869.
296.
1991

D.L. Goad; C.M. Davis; P. Liem; C.C. Fuselier; J.R. McCormack; K.M. Olsen

The use of selegiline in Alzheimer's patients with behavior problems
Journal of Clinical Psychiatry 1991;52(8):342-345.
297.
1991

A.A. Pappas; B.H. Ackerman; K.M. Olsen; E.H. Taylor

Isopropanol ingestion: A report of six episodes with isopropanol and acetone serum concentration time data
Journal of Toxicology - Clinical Toxicology 1991;29(1):11-21.
298.
1991

G.C. Yee

Recent advances in cyclosporine pharmacokinetics
Pharmacotherapy 1991;11(5):130S-134S.
299.
1991

G.C. Yee

Dosage forms of cyclosporine
Pharmacotherapy 1991;11(6):149S-152S.
300.
1990

B.A.P. Kostic; K.M. Olsen; G.L. Kearns; S.F. Kemp

Effect of glycated albumin on phenytoin binding in elderly patients with type II diabetes mellitus
Pharmacotherapy 1990;10(5):362-365.
301.
1991

W.P. Vaughan; J.D. Dennison; E.C. Reed; L. Klassen; T.R. McGuire; W.G. Sanger; P.P. Kumar; P.I. Warkentin; B.G. Gordon; P.J. Bierman; et al.

Improved results of allogeneic bone marrow transplantation for advanced hematologic malignancy using busulfan, cyclophosphamide and etoposide as cytoreductive and immunosuppressive therapy
Bone Marrow Transplantation 1991;8(6):489-495.
302.
1991

L.L. Bondoc Jr.; B.L. Robbins; G.S. Ahluwalia; H. Mitsuya; D.G. Johns; A. Fridland

Modulation of metabolism and anti-HIV-1 activity of purine 2',3'- dideoxynucleosides by IMP dehydrogenase inhibitors
Advances in Experimental Medicine and Biology 1991;309(Part A):49-53.
303.
1991

G.C. Yee

Colony stimulating factors for patients receiving cytotoxic chemotherapy. Both G-CSF and GM-CSF stimulate the production and activity of neutrophils, white blood cells that defend against bacteria
American Druggist 1991;204(3):64A-64B.
304.
1990

T.R. McGuire

Acute leukemia: detection and therapeutics.
American pharmacy 1990;NS30(2):29, 32-34.
305.
2011

Kimberly N. Bogard; Nicole T. Peterson; Troy J. Plumb; Michael W. Erwin; Patrick D. Fuller; Keith M. Olsen

Antibiotic dosing during sustained low-efficiency dialysis: Special considerations in adult critically ill patients
Critical Care Medicine 2011;39(3):560-570.
306.
2011

Donald G. Klepser; Liyan Xu; Fred Ullrich; Keith J. Mueller

Trends in Community Pharmacy Counts and Closures Before and After the Implementation of Medicare Part D
Journal of Rural Health 2011;27(2):168-175.
307.
2011

Ishaq Lat; Scott Micek; Jeffrey Janzen; Henry Cohen; Keith Olsen; Curtis Haas

Off-label medication use in adult critical care patients
Journal of Critical Care 2011;26(1):89-94.
308.
2011

Matthew L. Kelso; Nicole N. Scheff; Stephen W. Scheff; James R. Pauly

Melatonin and minocycline for combinatorial therapy to improve functional and histopathological deficits following traumatic brain injury
Neuroscience Letters 2011;488(1):60-64.
309.
2011

Adam M. Pitz; Fang Yu; Elizabeth D. Hermsen; Mark E. Rupp; Paul D. Fey; Keith M. Olsen

Vancomycin susceptibility trends and prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus in clinical methicillin-resistant S. aureus isolates
Journal of Clinical Microbiology 2011;49(1):269-274.
310.
2011

Matthew L. Kelso; James R. Pauly

Therapeutic targets for neuroprotection and/or enhancement of functional recovery following traumatic brain injury
Progress in Molecular Biology and Translational Science 2011;98(C):85-131.
311.
2011

Fulvia Veronese; Peter Anton; Courtney V. Fletcher; Victor DeGruttola; Ian McGowan; Stephen Becker; Sheryl Zwerski; David Burns

Implications of HIV PrEP trials results
AIDS Research and Human Retroviruses 2011;27(1):81-90.
312.
2011

Jeffrey N. Baldwin; David M. Scott; Edward M. DeSimone II; Joy H. Forrester; Martha P. Fankhauser

Substance use attitudes and behaviors at three pharmacy colleges
Substance Abuse 2011;32(1):27-35.
313.
2011

Katherine K. Knapp; Michael Manolakis; Andrew A. Webster; Keith M. Olsen

Projected growth in pharmacy education and research, 2010 to 2015
314.
2011

Julie H. Oestreich; Paul P. Dobesh

Platelet reactivity testing: An objective analysis of current capability
Acute Coronary Syndromes 2011;10(2):55-62.
315.
2011

Stephanie L. Freed; Connie A. Valente; Jennifer K. Hagerman; Donald G. Klepser; Michael E. Klepser

Assessment of the curricular content devoted to the application and interpretation of rapid diagnostic tests in colleges of pharmacy in the United States
Pharmacy Education 2011;11(1):205-208.
316.
2010

J. Chen; R.C. Garner; L.S. Lee; M. Seymour; E.J. Fuchs; W.C. Hubbard; T.L. Parsons; G.E. Pakes; C.V. Fletcher; C. Flexner

Accelerator mass spectrometry measurement of intracellular concentrations of active drug metabolites in human target cells in vivo
Clinical Pharmacology and Therapeutics 2010;88(6):796-800.
317.
2009

Paul P. Dobesh; Ann K. Wittkowsky; Zachary Stacy; William E. Dager; Stuart T. Haines; Larry M. Lopez; Edith Nutescu; Katherine W. Phillips; Toby C. Trujillo; Tom Vondracek

Key Articles and Guidelines for the Prevention of Venous Thromboembolism
Pharmacotherapy 2009;29(4):410-458.
318.
2009

Julie H. Oestreich; Steven R. Steinhubl

Cangrelor in percutaneous coronary intervention
Expert Review of Clinical Pharmacology 2009;2(2):137-145.
319.
2009

Jeffrey N. Baldwin

Meet the president
320.
2009

Timothy J. Wilkin; John E. McKinnon; A. Gregory DiRienzo; Katie Mollan; Courtney V. Fletcher; David M. Margolis; Barbara Bastow; Gary Thal; William Woodward; Catherine Godfrey; et al.

Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: Final 48-week clinical and virologic outcomes
Journal of Infectious Diseases 2009;199(6):866-871.
321.
2009

Ellen Gould Chadwick; Jorge Pinto; Ram Yogev; Carmelita G. Alvero; Michael D. Hughes; Paul Palumbo; Brian Robbins; Rohan Hazra; Leslie Serchuck; Barbara E. Heckman; et al.

Early initiation of lopinavir/ritonavir in infants less than 6 weeks of age: Pharmacokinetics and 24-week safety and efficacy
Pediatric Infectious Disease Journal 2009;28(3):215-219.
322.
2009

Julie H. Oestreich; Susan S. Smyth; Charles L. Campbell

Platelet function analysis: At the edge of meaning
Thrombosis and Haemostasis 2009;101(2):217-219.
323.
2009

Matthew L Kelso; Stephen W Scheff; James R Pauly; Charles D Loftin

Effects of genetic deficiency of cyclooxygenase-1 or cyclooxygenase-2 on functional and histological outcomes following traumatic brain injury in mice.
BMC neuroscience 2009;10():108-.
324.
2009

Jeffrey N. Baldwin

Vision 20/20: Expanding pharmacy's educational horizons
325.
2009

Jeffrey N. Baldwin

The addicts among us
326.
2008

Paul P. Dobesh; Stuart T. Haines; Katherine W. Phillips

Bias in AJHP supplements [2]
American Journal of Health-System Pharmacy 2008;65(24):2329-2330.
327.
2008

John M. Brooks; Elizabeth J. Unni; Donald G. Klepser; Julie M. Urmie; Karen B. Farris; William R. Doucette

Factors affecting demand among older adults for medication therapy management services
Research in Social and Administrative Pharmacy 2008;4(4):309-319.
328.
2008

Donald G. Klepser

Are patent expirations the answer to improving patient adherence?
American Journal of Managed Care 2008;14(12):787-788.
329.
2008

Brian L. Robbins; Edmund V. Capparelli; Ellen G. Chadwick; Ram Yogev; Leslie Serchuck; Carol Worrell; Mary Elizabeth Smith; Carmelita Alvero; Terence Fenton; et al.

Pharmacokinetics of high-dose lopinavir-ritonavir with and without saquinavir or nonnucleoside reverse transcriptase inhibitors in human immunodeficiency virus-infected pediatric and adolescent patients previously treated with protease inhibitors
Antimicrobial Agents and Chemotherapy 2008;52(9):3276-3283.
330.
2008

Jeffrey N. Baldwin; R. Ellen Davis-Hall; Edward M. DeSimone II; David M. Scott; Sangeeta Agrawal; Thomas P. Reardon

Survey of attitudes and behaviors toward alcohol and other drug use in allied health and physician assistant students
Journal of Allied Health 2008;37(3):156-161.
331.
2008

Elizabeth D. Hermsen; Sara S. Shull; Donald G. Klepser; Peter C. Iwen; Amy Armbrust; Jodi Garrett; Alison G. Freifeld; Mark E. Rupp

Pharmacoeconomic analysis of microbiologic techniques for differentiating staphylococci directly from blood culture bottles
Journal of Clinical Microbiology 2008;46(9):2924-2929.
332.
2006

J.W. Devlin; A. Bakshi; K. Bungay; K.M. Olsen

An in vitro comparison of different providers to deliver four proton pump inhibitor products through a feeding tube
Alimentary Pharmacology and Therapeutics 2006;24(11-12):1603-1611.
333.
2006

Tracy King; Lane Bushman; Jennifer Kiser; Peter L. Anderson; Michelle Ray; Thomas Delahunty; Courtney V. Fletcher

Liquid chromatography-tandem mass spectrometric determination of tenofovir-diphosphate in human peripheral blood mononuclear cells
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 2006;843(2):147-156.
334.
2006

Jeffrey N. Baldwin; David M. Scott; Sangeeta Agrawal; Jean K. Bartek; R. Ellen Davis-Hall; Thomas P. Reardon; Edward M. DeSimone II

Assessment of alcohol and other drug use behaviors in health professions students
Substance Abuse 2006;27(3):27-37.
335.
2006

Christina L. Aquilante; Taimour Y. Langaee; Peter L. Anderson; Issam Zineh; Courtney V. Fletcher

Multiplex PCR-pyrosequencing assay for genotyping CYP3A5 polymorphisms
Clinica Chimica Acta 2006;372(1-2):195-198.
336.
2006

Paul P. Dobesh

Stable angina: Current state of disease management
Journal of Managed Care Pharmacy 2006;12(8 SUPPL.):S4-S9.
337.
2006

Paul P. Dobesh; John Bosso; Suzanne Wortman; William E. Dager; Emilie L. Karpiuk; Qing Ma; Barbara J. Zarowitz

Critical pathways: The role of pharmacy today and tomorrow
Pharmacotherapy 2006;26(9 I):1358-1368.
338.
2006

Edith A. Nutescu; Ann K. Wittkowsky; Paul P. Dobesh; David W. Hawkins; William E. Dager

Choosing the appropriate antithrombotic agent for the prevention and treatment of VTE: A case-based approach
Annals of Pharmacotherapy 2006;40(9):1558-1571.
339.
2006

Susan Swindells; A. Gregory DiRienzo; Timothy Wilkin; Courtney V. Fletcher; David M. Margolis; Gary D. Thal; Catherine Godfrey; Barbara Bastow; M. Graham Ray; Hongying Wang; et al.

Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy after sustained virologic suppression
Journal of the American Medical Association 2006;296(7):806-814.
340.
2006

Peter L. Anderson; Jatinder Lamba; Christina L. Aquilante; Erin Schuetz; Courtney V. Fletcher

Pharmacogenetic characteristics of indinavir, zidovudine, and lamivudine therapy in HIV-infected adults: A pilot study
Journal of Acquired Immune Deficiency Syndromes 2006;42(4):441-449.
341.
2006

William T. Shearer; Jaime G. DeVille; Pearl M. Samson; John H. Moye Jr.; Courtney V. Fletcher; Joseph A. Church; Hans M.L. Spiegel; Paul Palumbo; Terence Fenton; M. Elizabeth Smith; et al.

Susceptibility of pediatric HIV-1 isolates to recombinant CD4-IgG2 (PRO 542) and humanized mAb to the chemokine receptor CCR5 (PRO 140)
Journal of Allergy and Clinical Immunology 2006;118(2):518-521.
342.
2006

Zexun Zhou; John H. Rodman; Patricia M. Flynn; Brian L. Robbins; Carrie K. Wilcox; David Z. D'Argenio

Model for intracellular lamivudine metabolism in peripheral blood mononuclear cells ex vivo and in human immunodeficiency virus type 1-infected adolescents
Antimicrobial Agents and Chemotherapy 2006;50(8):2686-2694.
343.
2004

Keith M. Olsen; Maria I. Rudis; Jill A. Rebuck; Jill Hara; Dave Gelmont; Ramin Mehdian; Casey Nelson; Mark E. Rupp

Effect of once-daily dosing vs. multiple daily dosing of tobramycin on enzyme markers of nephrotoxicity
Critical Care Medicine 2004;32(8):1678-1682.
344.
2004

Paul P. Dobesh

Evidence for extended prophylaxis in the setting of orthopedic surgery
Pharmacotherapy 2004;24(7 II):73S-81S.
345.
2004

Linda Ohler; Agnes Lo; Meredith Aull; Steve Gabardi; Jamie Park; Paula Phongsamran; Jennifer Trofe; Robyn Boardman; Dean Collier; Kathleen Lake; et al.

Transplant pharmacists: Key to a successful transplant program
Progress in Transplantation 2004;14(2):80-81.
346.
2004

Courtney V. Fletcher; Ram Yogev; Sharon A. Nachman; Andrew Wiznia; Stephen Pelton; Kenneth McIntosh; Kenneth Stanley

Pharmacokinetic Characteristics of Ritonavir, Zidovudine, Lamivudine, and Stavudine in Children with Human Immunodeficiency Virus Infection
Pharmacotherapy 2004;24(4):453-459.
347.
2004

Courtney V. Fletcher; Hongyu Jiang; Richard C. Brundage; Edward P. Acosta; Richard Haubrich; David Katzenstein; Roy M. Gulick

Sex-based differences in saquinavir pharmacology and virologic response in AIDS Clinical Trials group study 359
Journal of Infectious Diseases 2004;189(7):1176-1184.
348.
2004

Akihiko Saitoh; Christine A. Powell; Terence Fenton; Steven D. Douglas; Stuart E. Starr; Courtney V. Fletcher; Stephen A. Spector

Longitudinal analysis of lymphocyte ratios and HIV-1 intracellular DNA levels in children
Journal of Infectious Diseases 2004;189(7):1216-1220.
349.
2004

Peter L Anderson; Courtney V Fletcher

Updated clinical pharmacologic considerations for HIV-1 protease inhibitors.
Curr HIV/AIDS Rep 2004;1(1):33-39.
350.
2004

Paul P. Dobesh; Sara D. Brouse; Daniel C. Johnson; William E. Dager; Dawn Bell; Denise E. Daly; Jacqueline L. Olin; Anna M. Wodlinger

Key Articles and Guidelines Relative to Treatment of Patients with Acute Coronary Syndromes
Pharmacotherapy 2004;24(1):105-144.
351.
2004

Richard C. Brundage; Florence H. Yong; Terence Fenton; Stephen A. Spector; Stuart E. Starr; Courtney V. Fletcher

Intrapatient Variability of Efavirenz Concentrations as a Predictor of Virologic Response to Antiretroviral Therapy
Antimicrobial Agents and Chemotherapy 2004;48(3):979-984.
352.
2004

Sandy Kane-Gill; Keith M. Olsen

How to Write an Abstract Suitable for Publication
Hospital Pharmacy 2004;39(3):289-292.
353.
2004

Courtney V. Fletcher

Antiretroviral therapy for HIV-infected infants: Progress and pitfalls
AIDS 2004;18(2):325-326.
354.
2004

Dean R. Keller; David V. O'Dell; Susan E. Skochelak; Gary L. Cochran; Sara J. Shull; Craig L. Gjerde

Teaching the Basics of Clinical Pharmaceutical Care: Innovative Pharmacy Workshops at the University of Wisconsin and the University of Nebraska
Family Medicine 2004;36(SUPPL.):S89-S92.
355.
2004

Timothy R. McGuire

Bortezomib (velcade). A new therapy for multiple myeloma
Clinical Research and Regulatory Affairs 2004;21(1):29-38.
356.
2003

Jason M. Enders; Paul P. Dobesh; James N. Ellison

Acute Myocardial Infarction Induced by Ephedrine Alkaloids
Pharmacotherapy 2003;23(12 I):1645-1651.
357.
2001

Jeffrey O. Phillips; Keith M. Olsen; Jill A. Rebuck; Nick J. Rangnekar; Brent W. Miedema; Michael H. Metzler

A randomized, pharmacokinetic and pharmacodynamic, cross-over study of duodenal or jejunal administration compared to nasogastric administration of omeprazole suspension in patients at risk for stress ulcers
American Journal of Gastroenterology 2001;96(2):367-372.
358.
2001

T.N. Kakuda; L.M. Page; P.L. Anderson; K. Henry; T.W. Schacker; F.S. Rhame; E.P. Acosta; R.C. Brundage; C.V. Fletcher

Pharmacological basis for concentration-controlled therapy with zidovudine, lamivudine, and indinavir
Antimicrobial Agents and Chemotherapy 2001;45(1):236-242.
359.
2001

T.R. McGuire; G.R. Bociek; S.Z. Pavletic; L. Hock; J. Lynch; J. Schneider; E.B. Hoie; S. Tarantolo; W.D. Haire

Organ dysfunction following stem cell transplantation: Relationship to plasma cytokine concentrations
Bone Marrow Transplantation 2001;28(9):889-893.
360.
2001

T.R. McGuire; A. Kessinger; L. Hock; J.G. Sharp

Elevated transforming growth factor beta levels in the plasma of cytokine-treated cancer patients and normal allogeneic stem cell donors
Cytotherapy 2001;3(5):361-364.
361.
2001

S. Buckman; D.S. Collier

Hepatitis B immune globulin: Product information and nursing implications
Progress in Transplantation 2001;11(4):261-263.
362.
2001

J.A. Rebuck; J.R. Rasmussen; K.M. Olsen

Clinical aspiration-related practice patterns in the intensive care unit: A physician survey
Critical Care Medicine 2001;29(12):2239-2244.
363.
2001

Gary C. Yee; Amy W. Valley

The 20001 guide to oncologic dosing: Part I
Oncology Spectrums 2001;2(9):657-667.
364.
2000

David M. Scott; Ronald J. Hospodka; Craig A. Pedersen; Allison M. D. Jorgensen

Pharmacists' assessment of technician use in Nebraska
American Journal of Health-System Pharmacy 2000;57(23):2206-2210.
365.
2000

Simon P. Horslen; James M. Hammel; Lance W. Fristoe; Jeff A. Kangas; Dean S. Collier; Debra L. Sudan; Alan N. Langnas; R. Stephen Dixon; Ernest D. Prentice; Byers W. Shaw Jr.; et al.

Extracorporeal liver perfusion using human and pig livers for acute liver failure
Transplantation 2000;70(10):1472-1478.
366.
2000

D.W. Haas; L.A. Clough; B.W. Johnson; V.L. Harris; P. Spearman; G.R. Wilkinson; C.V. Fletcher; S. Fiscus; S. Raffanti; R. Donlon; et al.

Evidence of a source of HIV type 1 within the central nervous system by ultraintensive sampling of cerebrospinal fluid and plasma
AIDS Research and Human Retroviruses 2000;16(15):1491-1502.
367.
2000

Courtney V. Fletcher; Richard C. Brundage; Rory P. Remmel; Linda M. Page; Dennis Weller; Nancy R. Calles; Cara Simon; Mark W. Kline

Pharmacologic characteristics of indinavir, didanosine, and stavudine in human immunodeficiency virus-infected children receiving combination therapy
Antimicrobial Agents and Chemotherapy 2000;44(4):1029-1034.
368.
2000

Bruce E. Hillner; James N. Ingle; James R. Berenson; Nora A. Janjan; Kathy S. Albain; Allan Lipton; Gary Yee; J. Sybil Biermann; Rowan T. Chlebowski; David G. Pfister

American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer
Journal of Clinical Oncology 2000;18(6):1378-1391.
369.
1997

J.H. Rodman; B.L. Robbins; P.M. Flynn; A. Fridland

Maternal and fetal pharmacokinetics (PK) of zidovudine(ZDV)
Clinical Pharmacology and Therapeutics 1997;61(2):211-.
370.
1997

T.E. Peddicord; D.S. Collier; K.M. Olsen

DNA synthesis of mononuclear cells exposed to lansoprazole, omeprazole, and ranitidine
Clinical Pharmacology and Therapeutics 1997;61(2):169-.
371.
1996

J.K. Bartek; M.J. McNamee; J.N. Baldwin; C.S. Meade

The sheltered homeless and medications: implications for health care.
Journal of the American Academy of Nurse Practitioners 1996;8(12):571-576.
372.
1996

Henry H. Balfour Jr.; Courtney V. Fletcher; Alejo Erice; W. Keith Henry; Edward P. Acosta; Scott A. Smith; Marlene A. Holm; Guy Boivin; David H. Shepp; Clyde S. Crumpacker; et al.

Effect of foscarnet on quantities of cytomegalovirus and human immunodeficiency virus in blood of persons with AIDS
Antimicrobial Agents and Chemotherapy 1996;40(12):2721-2726.
373.
1996

Courtney V. Fletcher; Henry H. Balfour Jr.

Variability in zidovudine serum concentrations
Pharmacotherapy 1996;16(6 I):1154-1158.
374.
1996

Keith M. Olsen; Gerardo S. San Pedro; Larry P. Gann; Paul O. Gubbins; David M. Halinski; G. Douglas Campbell Jr.

Intrapulmonary pharmacokinetics of azithromycin in healthy volunteers given five oral doses
Antimicrobial Agents and Chemotherapy 1996;40(11):2582-2585.
375.
1996

Brian L. Robbins; Brett H. Waibel; Arnold Fridland

Quantitation of intracellular zidovudine phosphates by use of combined cartridge-radioimmunoassay methodology
Antimicrobial Agents and Chemotherapy 1996;40(11):2651-2654.
376.
1996

Courtney V. Fletcher

Pharmacologic considerations for antiviral drug development
Annals of Pharmacotherapy 1996;30(9):972-977.
377.
1996

John H. Rodman; Brian Robbins; Patricia M. Flynn; Arnold Fridland

A systemic and cellular model for zidovudine plasma concentrations and intracellular phosphorylation in patients
Journal of Infectious Diseases 1996;174(3):490-499.
378.
1996

E.P. Acosta; K. Schwebke; K. Henry; C.V. Fletcher

Disposition of zidovudine in obese pregnant women with human immunodeficiency virus type 1 infection [4]
Journal of Infectious Diseases 1996;174(3):673-.
379.
1996

B.L. Robbins; A. Fridland

Metabolism and therapeutic activity of acyclic adenine phosphonate analogues
International Antiviral News 1996;4(4):57-58.
380.
1996

Timothy R. McGuire; Peter W. Kazakoff; Eric B. Hoie; Margery A. Fienhold

Antiproliferative activity of shark cartilage with and without tumor necrosis factor-α in human umbilical vein endothelium
Pharmacotherapy 1996;16(2 I):237-244.
381.
1996

Edward P. Acosta; Linda M. Page; Courtney V. Fletcher

Clinical Pharmacokinetics of Zidovudine: An Update
Clinical Pharmacokinetics 1996;30(4):251-262.
382.
1996

Mark W. Kline; Courtney V. Fletcher; Marianne E. Federici; Alice T. Harris; Kim D. Evans; Victoria L. Rutkiewicz; William T. Shearer; Lisa M. Dunkle

Combination therapy with stavudine and didanosine in children with advanced human immunodeficiency virus infection: Pharmacokinetic properties, safety, and immunologic and virologic effects
Pediatrics 1996;97(6 I):886-890.
383.
1993

J. Sankaranarayanan; C.I. Jolly

Phytochemical, antibacterial and pharmacological investigations on Momordica charantia Linn. Emblica officinalis gaertn. and Curcuma longa Linn.
Indian Journal of Pharmaceutical Sciences 1993;55(1):6-13.
384.
1996

G.C. Yee

The future of cell therapy
Pharmacotherapy 1996;16(3 II):109S-115S.
385.
1996

David Z. D'Argenio; John H. Rodman; Brian L. Robbins; Arnold Fridland

Modeling the cellular kinetics of the antiviral agents PMEA and PMPA
Annual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings 1996;5():1903-1904.
386.
1990

G.C. Yee; T.R. McGuire

Pharmacokinetic drug interactions with cyclosporin (Part I)
Clinical Pharmacokinetics 1990;19(4):319-332.
387.
1990

R.B. Sothern; F. Rhame; C. Suarez; C. Fletcher; L. Sackett-Lundeen; E. Haus; W.J. Hrushesky

Oral temperature rhythmometry and substantial within-day variation in zidovudine levels following steady-state dosing in human immunodeficiency virus (HIV) infection.
Progress in clinical and biological research 1990;341 A():67-76.
388.
1990

G.C. Yee

Focus on GM-CSF and G-CSF: Promising biotherapeutics for use in hematology and oncology
Hospital Formulary 1990;25(9):943-948.
389.
1990

G.C. Yee

Clinical pharmacology of cyclosporine
Nuclear Medicine and Biology 1990;17(7):729-732.
390.
1990

G.C. Yee; T.R. McGuire

Pharmacokinetic drug interactions with cyclosporin (part II)
Clinical Pharmacokinetics 1990;19(5):400-415.
391.
1990

G.P. Meier; S.B. Park; G.C. Yee; D.J. Gmur

Isolation and identification of a novel human metabolite of cyclosporin A: Dihydro-CsA M17
Drug Metabolism and Disposition 1990;18(1):68-71.
392.
1990

J.P. Engel; J.A. Englund; C.V. Fletcher; E.L. Hill

Treatment of resistant herpes simplex virus with continuous-infusion acyclovir
Journal of the American Medical Association 1990;263(12):1662-1664.
393.
1990

G.C. Yee

Pharmacokinetic and pharmacodynamic studies of cyclosporine in bone marrow transplantation
Transplantation Proceedings 1990;22(3):1327-1330.
394.
1990

C.V. Fletcher; D. Metzler; P. Borchardt-Phelps; J.H. Rodman

Patterns of antibiotic use and expenditures during 7 years at a University Hospital
Pharmacotherapy 1990;10(3):199-204.
395.
1990

G.C. Yee

Pharmacokinetic interactions between cyclosporine and other drugs
Transplantation Proceedings 1990;22(3):1203-1207.
396.
1990

B.H. Ackerman; K.M. Olsen; C.B. Padilla

Errors in assuming a one-compartment model for vancomycin
Therapeutic Drug Monitoring 1990;12(3):304-305.
397.
1990

K.M. Olsen; C.S. Pablo; B.H. Ackerman

Postoperative analgesic requirements following flumazenil administration
DICP, Annals of Pharmacotherapy 1990;24(12):1159-1163.
398.
1990

Gary C. Yee

Clinical pharmacology of cyclosporine
International Journal of Radiation Applications and Instrumentation. 1990;17(7):729-732.
399.
1989

K.M. Olsen; F.C. Hiller; B.H. Ackerman; B.J. McCabe

Effect of enteral feedings on oral phenytoin absorption.
Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition 1989;4(5):176-178.
400.
1989

B.H. Ackerman; K.M. Olsen; E.E. Kennedy; E.H. Taylor; B.H. Chen; D. Jordan; D.J. Ackerman

Disposition of 3-hydroxyquinidine in patients receiving initial intravenous quinidine gluconate for electrophysiology testing of ventricular tachycardia
DICP, Annals of Pharmacotherapy 1989;23(5):375-378.
401.
1989

K. O'Neill; B. Hurt; K.M. Olsen; B.H. Ackerman

Variance in quinidine maintenance dose prediction using four dosing methods
Therapeutic Drug Monitoring 1989;11(4):487-488.
402.
1989

C.V. Fletcher; J.A. Englund; B. Bean; B. Chinnock; D.M. Brundage; H.H. Balfour Jr.

Continuous infusion of high-dose acyclovir for serious herpesvirus infections
Antimicrobial Agents and Chemotherapy 1989;33(8):1375-1378.
403.
1989

G.C. Yee

Colony-stimulating factors and tomorrow's pharmacy: Why we must be ready
American Journal of Hospital Pharmacy 1989;46(11 SUPPL. 2):S24-S29.
404.
1989

B.H. Ackerman; K.M. Olsen; E.E. Kenndedy; E.H. Taylor; B.H. Chen; D. Jordan; D.J. Ackerman

Comparison of disposition values obtained by two assay methods for quinidine gluconate in patients with ventricular tachycardia
Pharmacotherapy 1989;9(4):220-225.
405.
1989

C.V. Fletcher; H.H. Balfour Jr.

Evaluation of ganciclovir for cytomegalovirus disease
DICP, Annals of Pharmacotherapy 1989;23(1):5-12.
406.
1989

G.C. Yee; T.R. McGuire; B.A. St Pierre; S.G. Self; R.A. Zager; K.M. Sullivan; H.J. Deeg

Minimal risk of chronic renal dysfunction in marrow transplant recipients treated with cyclosporine for 6 months
Bone Marrow Transplantation 1989;4(6):691-694.
407.
2010

Kelly M. Smith; Todd Sorensen; Kathryn A. Connor; Paul P. Dobesh; James D. Hoehns; Kristine B. Marcus; Steven E. Pass; Amy L. Seybert; Nancy L. Shapiro

Value of conducting pharmacy residency training - The organizational perspective
Pharmacotherapy 2010;30(12):490e-510e.
408.
2010

C.V. Fletcher

Drug interactions should be evaluated in patients
Clinical Pharmacology and Therapeutics 2010;88(5):585-587.
409.
2010

S.K. Brusnahan; T.R. McGuire; J.D. Jackson; J.T. Lane; K.L. Garvin; B.J. O'Kane; A.M. Berger; S.R. Tuljapurkar; M.A. Kessinger; J.G. Sharp

Human blood and marrow side population stem cell and Stro-1 positive bone marrow stromal cell numbers decline with age, with an increase in quality of surviving stem cells: Correlation with cytokines
Mechanisms of Ageing and Development 2010;131(11-12):718-722.
410.
2010

P. Dobesh

The importance of appropriate prophylaxis for the prevention of venous thromboembolism in at-risk medical patients
International Journal of Clinical Practice 2010;64(11):1554-1562.
411.
2010

Trevor Van Schooneveld; Susan Swindells; Sarah R. Nelson; Brian L. Robbins; Ryan Moore; Courtney V. Fletcher

Clinical evaluation of a dried blood spot assay for atazanavir
Antimicrobial Agents and Chemotherapy 2010;54(10):4124-4128.
412.
2010

Jayashri Sankaranarayanan

Patient-reported perceptions and safety behaviors in chemotherapy administration
Expert Review of Pharmacoeconomics and Outcomes Research 2010;10(5):509-512.
413.
2010

Paul P. Dobesh; Toby C. Trujillo

Anticoagulation in the management of non-ST-segment elevation acute coronary syndrome
Journal of Pharmacy Practice 2010;23(4):324-334.
414.
2010

Paul P. Dobesh; Toby C. Trujillo

Anticoagulation in the management of ST-segment elevation myocardial infarction
Journal of Pharmacy Practice 2010;23(4):335-343.
415.
2010

David C. Metz; Gerard J. Fulda; Keith M. Olsen; John T. Monyak; Steven G. Simonson; M.B. Sostek

Intravenous esomeprazole pharmacodynamics in critically ill patients
Current Medical Research and Opinion 2010;26(5):1141-1148.
416.
2010

Jaclyn J Dvoracek; Kristen M Cook; Donald G Klepser

Student-run low-income family medicine clinic: controlling costs while providing comprehensive medication management.
Journal of the American Pharmacists Association : JAPhA 2010;50(3):384-387.
417.
2010

Jayashri Sankaranarayanan; Shinobu Watanabe-Galloway; Junfeng Sun; Fang Qiu; Eugene C. Boilesen; Alan G. Thorson

Age and rural residence effects on accessing colorectal cancer treatments: A registry study
American Journal of Managed Care 2010;16(4):265-273.
418.
2008

Rita B. Effros; Courtney V. Fletcher; Kelly Gebo; Jeffrey B. Halter; William R. Hazzard; Frances McFarland Horne; Robin E. Huebner; Edward N. Janoff; Amy C. Justice; Daniel Kuritzkes; et al.

Workshop on HIV infection and aging: What is known and future research directions
Clinical Infectious Diseases 2008;47(4):542-553.
419.
2008

Paul P. Dobesh; Katherine W. Phillips; Stuart T. Haines

Improving the use of anticoagulant therapies in acutely ill medical patients
American Journal of Health-System Pharmacy 2008;65(15 SUPPL. 7):S5-S12.
420.
2008

Paul P. Dobesh; Katherine W. Phillips; Stuart T. Haines

Optimizing antithrombotic therapy in patients with non-ST-segment elevation acute coronary syndrome
American Journal of Health-System Pharmacy 2008;65(15 SUPPL. 7):S22-S28.
421.
2008

Katherine W. Phillips; Paul P. Dobesh; Stuart T. Haines

Considerations in using anticoagulant therapy in special patient populations
American Journal of Health-System Pharmacy 2008;65(15 SUPPL. 7):S13-S21.
422.
2008

K.M. Olsen; J.W. Devlin

Comparison of the enteral and intravenous lansoprazole pharmacodynamic responses in critically ill patients
Alimentary Pharmacology and Therapeutics 2008;28(3):326-333.
423.
2008

Donald Klepser; Liyan Xu; Fred Ullrich; Keith Mueller

Independently owned pharmacy closures in rural America.
424.
2008

Mauro S. Torno; Mallory D. Witt; Akihiko Saitoh; Courtney V. Fletcher

Successful use of reduced-dose efavirenz in a patient with human immunodeficiency virus infection: Case report and review of the literature
Pharmacotherapy 2008;28(6):782-787.
425.
2008

Judith S. Currier; Jens D. Lundgren; Courtney V. Fletcher; Marta Boffito; Richard Koup; Giuseppe Pantaleo

Editorial introductions
Current Opinion in HIV and AIDS 2008;3(3):vii-x.
426.
2008

Jennifer J. Kiser; Christina L. Aquilante; Peter L. Anderson; Tracy M. King; Monica L. Carten; Courtney V. Fletcher

Clinical and genetic determinants of intracellular tenofovir diphosphate concentrations in HIV-infected patients
Journal of Acquired Immune Deficiency Syndromes 2008;47(3):298-303.
427.
2008

John M. Brooks; William R. Doucette; Shaowei Wan; Donald G. Klepser

Retail pharmacy market structure and performance
Inquiry 2008;45(1):75-88.
428.
2008

John E. Schneider; Pengxiang Li; Donald G. Klepser; N. Andrew Peterson; Timothy T. Brown; Richard M. Scheffler

The effect of physician and health plan market concentration on prices in commercial health insurance markets
International Journal of Health Care Finance and Economics 2008;8(1):13-26.
429.
2008

C.V. Fletcher; R.C. Brundage; T. Fenton; C.G. Alvero; C. Powell; L.M. Mofenson; S.A. Spector

Pharmacokinetics and pharmacodynamics of efavirenz and nelfinavir in HIV-infected children participating in an area-under-the-curve controlled trial
Clinical Pharmacology and Therapeutics 2008;83(2):300-306.
430.
2006

Jayashri Sankaranarayanan; Susan E. Puumala; Christopher J. Kratochvil

Diagnosis and treatment of adult attention-deficit/hyperactivity disorder at US ambulatory care visits from 1996 to 2003
Current Medical Research and Opinion 2006;22(8):1475-1491.
431.
2006

Zachary A. Stacy; Paul P. Dobesh; Toby C. Trujillo

Cardiovascular risks of cyclooxygenase inhibition
Pharmacotherapy 2006;26(7 I):919-938.
432.
2006

Paul P. Dobesh

Managing hypertension in patients with type 2 diabetes mellitus
American Journal of Health-System Pharmacy 2006;63(12):1140-1149.
433.
2006

John E. Murphy; Jean M. Nappi; John A. Bosso; Joseph J. Saseen; Brian A. Hemstreet; Mary Ann Halloran; Sarah A. Spinler; Timothy E. Welty; Paul P. Dobesh; Lingtak-Neander Chan; et al.

American College of Clinical Pharmacy's vision of the future: Postgraduate pharmacy residency training as a prerequisite for direct patient care practice
Pharmacotherapy 2006;26(5 I):722-733.
434.
2006

John W. Devlin; Keith M. Olsen

Authors' reply [5]
Annals of Pharmacotherapy 2006;40(5):997-998.
435.
2006

Matthew L. Kelso; Jeanne M. Wehner; Allan C. Collins; Stephen W. Scheff; James R. Pauly

The pathophysiology of traumatic brain injury in α7 nicotinic cholinergic receptor knockout mice
Brain Research 2006;1083(1):204-210.
436.
2006

Jennifer J. Kiser; Kenneth A. Lichtenstein; Peter L. Anderson; Courtney V. Fletcher

Effects of esomeprazole on the pharmacokinetics of atazanavir and fosamprenavir in a patient with human immunodeficiency virus infection
Pharmacotherapy 2006;26(4):511-514.
437.
2006

Tom Delahunty; Lane Bushman; Courtney V. Fletcher

Sensitive assay for determining plasma tenofovir concentrations by LC/MS/MS
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 2006;830(1):6-12.
438.
2006

Akihiko Saitoh; Kumud K. Singh; Sharsti Sandall; Christine A. Powell; Terrence Fenton; Courtney V. Fletcher; Karen Hsia; Stephen A. Spector

Association of CD4 ⁺ T-lymphocyte counts and new thymic emigrants in HIV-infected children during successful highly active antiretroviral therapy
Journal of Allergy and Clinical Immunology 2006;117(4):909-915.
439.
2006

Tracy King; Lane Bushman; Peter L. Anderson; Thomas Delahunty; Michelle Ray; Courtney V. Fletcher

Quantitation of zidovudine triphosphate concentrations from human peripheral blood mononuclear cells by anion exchange solid phase extraction and liquid chromatography-tandem mass spectroscopy; an indirect quantitation methodology
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 2006;831(1-2):248-257.
440.
2006

Heather J. Ribaudo; David W. Haas; Camlin Tierney; Richard B. Kim; Grant R. Wilkinson; Roy M. Gulick; David B. Clifford; Catia Marzolini; Courtney V. Fletcher; et al.

Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: An adult AIDS clinical trials group study
Clinical Infectious Diseases 2006;42(3):401-407.
441.
2006

Keith M. Olsen; Martha Gentry-Nielsen; Mei Yue; Mary U. Snitily; Laurel C. Preheim

Effect of ethanol on fluoroquinolone efficacy in a rat model of pneumococcal pneumonia
Antimicrobial Agents and Chemotherapy 2006;50(1):210-219.
442.
2003

Paul P Dobesh

Novel concepts: emerging data and the role of extended prophylaxis following hip fracture surgery.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2003;60(22 Suppl 7):S15-19.
443.
2003

Bruce E. Hillner; James N. Ingle; Rowan T. Chlebowski; Julie Gralow; Gary C. Yee; Nora A. Janjan; Jane A. Cauley; Brent A. Blumenstein; Kathy S. Albain; Allan Lipton; et al.

American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer
Journal of Clinical Oncology 2003;21(21):4042-4057.
444.
2003

Peter L. Anderson; Thomas N. Kakuda; Sagar Kawle; Courtney V. Fletcher

Antiviral dynamics and sex differences of zidovudine and lamivudine triphosphate concentrations in HIV-infected individuals
AIDS 2003;17(15):2159-2168.
445.
2003

Paul P. Dobesh; Sara L. Lanfear; Joy R. Abu-Shanab; Jonathan E. Lakamp; Siddhesh Gowda; Maged Y. Haikal

Outcomes with changes in prescribing of glycoprotein IIb/IIIa inhibitors in PCI
Annals of Pharmacotherapy 2003;37(10):1375-1380.
446.
2003

Dorie W. Hoody; Courtney V. Fletcher

Pharmacology Considerations for Antiretroviral Therapy in Human Immunodeficiency Virus (HIV)-Infected Children
Seminars in Pediatric Infectious Diseases 2003;14(4):286-294.
447.
2003

Steven Z. Pavletic; R. Gregory Bociek; James M. Foran; Ronald J. Rubocki; Charles A. Kuszynski; James L. Wisecarver; Lori Hatcher; David M. Lucas; John C. Byrd; Michael R. Grever; et al.

Lymphodepleting effects and safety of pentostatin for nonmyeloablative allogeneic stem-cell transplantation
Transplantation 2003;76(5):877-881.
448.
2003

Phillip J Vuchetich; Robert I Garis; Allison M D Jorgensen

Evaluation of cost savings to a state Medicaid program following a sertraline tablet-splitting program.
Journal of the American Pharmacists Association : JAPhA 2003;43(4):497-502.
449.
2003

Timothy R. McGuire; Eric B. Hoie; Konstantine K. Manouilov; Peter G. Gwilt

The effect of hydroxyurea on the phosphorylation of zidovudine and lamivudine in human umbilical vein endothelial cells
In Vitro Cellular and Developmental Biology - Animal 2003;39(7):280-282.
450.
2003

Brian L. Robbins; Carrie K. Wilcox; Arnold Fridland; John H. Rodman

Metabolism of tenofovir and didanosine in quiescent or stimulated human peripheral blood mononuclear cells
Pharmacotherapy 2003;23(6):695-701.
451.
2003

Courtney V. Fletcher

Enfuvirtide, a new drug for HIV infection
Lancet 2003;361(9369):1577-1578.
452.
2000

P.L. Anderson; R.C. Brundage; L. Bushman; T.N. Kakuda; R.P. Remmel; C.V. Fletcher

Indinavir plasma protein binding in HIV-1-infected adults
AIDS 2000;14(15):2293-2297.
453.
2000

A. Fridland; M.C. Connelly; B.L. Robbins

Cellular factors for resistance against antiretroviral agents
Antiviral Therapy 2000;5(3):181-185.
454.
2000

Courtney V. Fletcher; Sagar P. Kawle; Thomas N. Kakuda; Peter L. Anderson; Dennis Weller; Lane R. Bushman; Richard C. Brundage; Rory P. Remmel

Zidovudine triphosphate and lamivudine triphosphate concentration-response relationships in HIV-infected persons
AIDS 2000;14(14):2137-2144.
455.
2000

R.M. Gulick; X.J. Hu; S.A. Fiscus; C.V. Fletcher; R. Haubrich; H. Cheng; E. Acosta; S.W. Lagakos; R. Swanstrom; W. Freimuth; et al.

Randomized study of saquinavir with ritonavir or nelfinavir together with delavirdine, adefovir, or both in human immunodeficiency virus-infected adults with virologic failure on indinavir: AIDS Clinical Trials Group study 359
Journal of Infectious Diseases 2000;182(5):1375-1384.
456.
2000

Jill A. Rebuck; Keith M. Olsen; Paul D. Fey; Kimberly L. Bergman; Mark E. Rupp

In vitro activities of parenteral β-lactam antimicrobials against TEM-10, TEM-26- and SHV-5-derived extended-spectrum β-lactamases expressed in an isogenic Escherichia coli host
Journal of Antimicrobial Chemotherapy 2000;46(3):461-464.
457.
2000

P.L. Anderson; S.E. Noormohamed; K. Henry; R.C. Brundage; Jr. Balfour H.H.; C.V. Fletcher

Semen and serum pharmacokinetics of zidovudine and zidovudine-glucuronide in men with HIV-1 infection
Pharmacotherapy 2000;20(8 I):917-922.
458.
2000

Stephani Leflore; Peter L. Anderson; Courtney V. Fletcher

A risk-benefit evaluation of aciclovir for the treatment and prophylaxis of herpes simplex virus infections
Drug Safety 2000;23(2):131-142.
459.
2000

Jeffrey M. Jacobson; Israel Lowy; Courtney V. Fletcher; Tobias J. Neill; Diep N. H. Tran; Thomas J. Ketas; Alexandra Trkola; Mary E. Klotman; Paul J. Maddon; et al.

Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adults
Journal of Infectious Diseases 2000;182(1):326-329.
460.
2000

J.E. Lakamp; P.P. Dobesh

Propofol and too much sulfite? [5]
Chest 2000;118(1):277-.
461.
2000

Keith M. Olsen; Tom E. Peddicord; G. Douglas Campbell; Mark E. Rupp

Antimicrobial effects of lidocaine in bronchoalveolar lavage fluid
Journal of Antimicrobial Chemotherapy 2000;45(2):217-219.
462.
2000

Rory P. Remmel; Sagar P. Kawle; Dennis Weller; Courtney V. Fletcher

Simultaneous HPLC assay for quantification of indinavir, nelfinavir, ritonavir, and saquinavir in human plasma
Clinical Chemistry 2000;46(1):73-81.
463.
2000

E. Richard Stiehm; Courtney V. Fletcher; Lynne M. Mofenson; Paul E. Palumbo; Minhee Kang; Terry Fenton; Christine V. Sapan; William A. Meyer III; William T. Shearer; Elizabeth Hawkins; et al.

Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulin in HIV type 1-infected children (Pediatric AIDS Clinical Trials Group Protocol 273)
Journal of Infectious Diseases 2000;181(2):548-554.
464.
2000

Jennifer L. DiGiacinto; Keith M. Olsen; Kimberly L. Bergman; Eric B. Hoie

Stability of suspension formulations of lansoprazole and omeprazole stored in amber-colored plastic oral syringes
Annals of Pharmacotherapy 2000;34(5):600-605.
465.
2000

Brian L. Robbins; Jack Greenhaw; Arnold Fridland

Cellular phosphorylation of 2',3'-dideoxyadenosine-5'-monophosphate, a key intermediate in the activation of the antiviral agent ddI, in human peripheral blood mononuclear cells
Nucleosides, Nucleotides and Nucleic Acids 2000;19(1-2):405-413.
466.
2000

Keith M. Olsen; Jill A. Rebuck; Tavis Weidenbach; Douglas N. Fish

Pharmacokinetics of intravenous trovafloxacin in critically ill adults
Pharmacotherapy 2000;20(4):400-404.
467.
1996

Gary C. Yee

The future of cell therapy
Pharmacotherapy 1996;16(3 II):1095-1155.
468.
1995

Keith M. Olsen; F.Charles Hiller; Bruce H. Ackerman; Kelly Crisp-Landwehr; Gerardo S. San Pedro

Effect of single intravenous doses of histamine2-receptor antagonists on volume and pH of gastric acid secretions in critically ill patients
Current Therapeutic Research 1995;56(8):756-768.
469.
1995

S.E. Noormohamed; W.K. Henry; F.S. Rhame; H.H. Balfour Jr.; C.V. Fletcher

Strategies for control of zidovudine concentrations in serum
Antimicrobial Agents and Chemotherapy 1995;39(12):2792-2797.
470.
1995

L.L. Briceland; J.D. Cleary; C.V. Fletcher; D.P. Healy; C.A. Peloquin

Recent advances: Antiinfectives
Annals of Pharmacotherapy 1995;29(10):1035-1040.
471.
1995

M.S. Shaefer; S.J. Rossi; T.R. McGuire; L.J. Schaaf; D.S. Collier; R.J. Stratta

Evaluation of the pharmacokinetic interaction between cimetidine or famotidine and cyclosporine in healthy men
Annals of Pharmacotherapy 1995;29(11):1088-1091.
472.
1995

C.V. Fletcher; W.K. Henry; S.E. Noormohamed; F.S. Rhame; H.H. Balfour Jr.

The effect of cimetidine and ranitidine administration with zidovudine
Pharmacotherapy 1995;15(6 I):701-708.
473.
1995

M.S. Monaghan; K.M. Olsen; B.H. Ackerman; G.L. Fuller; W.H. Porter; A.A. Pappas

Measurement of serum isopropanol and the acetone metabolite by proton nuclear magnetic resonance: Application to pharmacokinetic evaluation in a simulated overdose model
Journal of Toxicology - Clinical Toxicology 1995;33(2):141-149.
474.
1995

B.L. Robbins; M.C. Connelly; D.R. Marshall; R.V. Srinivas; A. Fridland

A human T lymphoid cell variant resistant to the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl)adenine shows a unique combination of a phosphorylation defect and increased efflux of the agent
Molecular Pharmacology 1995;47(2):391-397.
475.
1995

E.P. Acosta; C.V. Fletcher

Antiretroviral drug interactions
International Journal of Antimicrobial Agents 1995;5(2):73-83.
476.
1995

Gary C. Yee; Denise L. Stanley; Lisa J. Pessa; Teresa Dalla Costa; Susan E. Beltz; Jorge Ruiz; David T. Lowenthal

Effect of grapefruit juice on blood cyclosporin concentration
Lancet 1995;345(8955):955-956.
477.
1995

K.M. Olsen; B.J. Gurley; G.A. Davis; S.R. Archer; F.H. Ma; B.H. Ackerman

Comparison of fluid volumes with whole bowel irrigation in a simulated overdose of ibuprofen
Annals of Pharmacotherapy 1995;29(3):246-250.
478.
1995

K. Schwebke; C.V. Fletcher; E.P. Acosta; K. Henry

Pentamidine concentrations in a mother with AIDS and in her neonate [5]
Clinical Infectious Diseases 1995;20(6):1569-1570.
479.
1995

A. Johnston; D.W. Holt; A.A.M.J. Hollander; F.J. Van der Woude; A.F. Cohen; G.C. Yee; D.T. Lowenthal

Effect of grapefruit juice on blood cyclosporin concentration [11]
Lancet 1995;346(8967):122-124.
480.
1995

K.M. Olsen; G.L. Kearns; S.F. Kemp

Glyburide protein binding and the effect of albumin glycation in children, young adults, and older adults with diabetes
Journal of Clinical Pharmacology 1995;35(7):739-745.
481.
1995

B.J. Gurley; M. Marx; K. Olsen

Phenytoin free fraction determination: Comparison of an improved direct serum injection high-performance liquid chromatographic method to ultrafiltration coupled with fluorescence polarization immunoassay
Journal of Chromatography B: Biomedical Applications 1995;670(2):358-364.
482.
1988

G.C. Yee; T.R. McGuire; D.J. Gmur; T.P. Lennon; H.J. Deeg

Blood cyclosporine pharmacokinetics in patients undergoing marrow transplantation. Influence of age, obesity, and hematocrit
Transplantation 1988;46(3):399-402.
483.
1988

T.R. Mcguire; M.S. Tallman; G.C. Yee; J.J. Nemunaitis; C.S. Higano; R.W. McGuffin; J.W. Singer

Influence of infusion duration of the efficacy and toxicity of intravenous cyclosporine in bone marrow transplant patients
Transplantation Proceedings 1988;20(3 SUPPL. 3):501-504.
484.
1988

H. Schmidt; H. Einselle; K. Jaschonek; R. Dopper; G. Ehninger; A. Glazier; G.C. Yee; H.J. Deeg

Cyclosporine and graft-versus-host disease after bone marrow transplantation
New England Journal of Medicine 1988;319(24):1607-1608.
485.
1987

G.C. Yee

Drugs that affect the blood concentration of cyclosporin.
Bone Marrow Transplantation 1987;2(4):451-452.
486.
1987

G.C. Yee

Bone marrow transplantation
Pharmacotherapy 1987;7(2):S23-S27.
487.
1988

K.M. Sullivan; R.P. Witherspoon; R. Storb; H.J. Deeg; S. Dahlberg; J.E. Sanders; F.R. Appelbaum; K.C. Doney; P. Weiden; et al.

Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease
Blood 1988;72(2):555-561.
488.
1988

C.V. Fletcher; B.J. Chinnock; B. Chace; H.H. Balfour Jr.

Pharmacokinetics and safety of high-dose oral acyclovir for suppression of cytomegalovirus disease after renal transplantation
Clinical Pharmacology and Therapeutics 1988;44(2):158-163.
489.
1988

J.D. Cleary; D. Weisdorf; C.V. Fletcher

Effect of infusion rate on amphotericin B-associated febrile reactions
Drug Intelligence and Clinical Pharmacy 1988;22(10):769-772.
490.
1988

K.D. Lake; C.V. Fletcher; K.R. Love; D.C. Brown; L.D. Joyce; M.R. Pritzker

Ganciclovir pharmacokinetics during renal impairment
Antimicrobial Agents and Chemotherapy 1988;32(12):1899-1900.
491.
1988

B.H. Chen; E.H. Taylor; B.H. Ackerman; K. Olsen; A.A. Pappas

Effect of pH on free quinidine
Drug Intelligence and Clinical Pharmacy 1988;22(10):826-.
492.
1988

G.C. Yee; T.P. Lennon; D.J. Gmur; C.L. Cheney; D. Oeser; H.J. Deeg

Effect of obesity on cyclosporine disposition
Transplantation 1988;45(3):649-651.
493.
1988

G.C. Yee; S.G. Self; T.R. McGuire; J. Carlin; J.E. Sanders; H.J. Deeg

Serum cyclosporine concentration and risk of acute graft-versus-host disease after allogeneic marrow transplantation
New England Journal of Medicine 1988;319(2):65-70.
494.
1988

Y.-H. Tu; M.L. Stiles; L.V. Allen Jr.; K.M. Olsen; C.I. Barton; R.B. Greenwood

Stability of amoxicillin trihydrate-potassium clavulanate in original containers and unit dose oral syringes
American Journal of Hospital Pharmacy 1988;45(5):1092-1099.
495.
1988

B.H. Ackerman; E.H. Taylor; K.M. Olsen; W. Abdel-Malak; A.A. Pappas

Vancomycin serum protein binding determination by ultrafiltration
Drug Intelligence and Clinical Pharmacy 1988;22(4):300-303.
496.
1988

B.H. Chen; E.H. Taylor; E. Kennedy; B. Ackerman; K. Olsen; A.A. Pappas

Total and free quinidine by fluorescence polarization immunoassay and comparison with high performance liquid chromatography
Clinica Chimica Acta 1988;175(1):107-108.
497.
1988

M.S. Tallman; J.J. Nemunaitis; T.R. McGuire; G.C. Yee; T.E. Hughes; J.D. Almgren; F.R. Appelbaum; C.S. Higano; R.W. McGuffin; J.W. Singer; et al.

Comparison of two intravenous cyclosporine infusion schedules in marrow transplant recipients
Transplantation 1988;45(4):810-813.
498.
1988

G.C. Yee; D.J. Gmur; P. Meier

Measurement of blood cyclosporine metabolite concentrations with a new column-switching high-performance liquid chromatographic assay
Transplantation Proceedings 1988;20(2 SUPPL. 2):585-590.
499.
1988

D.J. Gmur; P. Meier; G.C. Yee

High-performance liquid chromatographic column-switching method for two cyclosporine metabolites in blood
Journal of Chromatography - Biomedical Applications 1988;425(2):343-352.
500.
1988

K. Henry; B.J. Chinnock; R.P. Quinn; C.V. Fletcher; P. De Miranda; H.H. Balfour Jr.

Concurrent zidovudine levels in semen and serum determined by radioimmunoassay in patients with AIDS or AIDS-related complex
Journal of the American Medical Association 1988;259(20):3023-3026.

Pharmacy Practice University of Nebraska Medical Center

Publications

Publications from Scopus

Pharmacy Practice
University of Nebraska Medical Center